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Glaucoma is the second leading cause of blindness worldwide, affecting approximately 
67 million people and costing the US healthcare system an estimated $2.5 billion 
annually. The greatest risk factor for the diagnosis and progression of glaucoma is high 
eye pressure. All glaucoma medications and procedures are designed to reduce eye 
pressure, slowing disease progression and preserving vision.   
The eye’s aqueous humor nourishes avascular tissues in the anterior segment.  It 
also maintains the eye’s geometry by pressurizing the globe, facilitating its ability to 
focus light on the retina.  The balance between aqueous humor production and uptake is 
responsible for the pressure within the eye. Most glaucoma medications are designed to 
reduce pressure by increasing aqueous humor outflow, and surgeries are designed to 
enhance or bypass exiting outflow pathways.  But, the effects of medications and 
procedures on a patient by patient basis on outflow remain speculative.  
Here, techniques for the non-invasive direct mapping and measurement of 
aqueous humor outflow in the living human eye are proposed.  Mapping provides 
morphometric insights and measurements of the components of the outflow system, while 
the flow technique is the first to provide direct measurements of outflow, free of the 
assumptions plaguing other modalities.   “Virtual casting” of the outflow system yields 
3D maps from which terminal branches are identified.  Doppler measurements quantify 
velocity within those branches. Total aqueous humor outflow is determined by 
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 ? 
integrating calculated flow across all identified terminal branches.  These technologies 
can be adapted to existing FDA approved OCT clinical scanners.  Clinical application of 
these technologies may improve the management of glaucoma by reducing the time 
needed to determine and implement optimal therapeutic strategies, thereby preserving 
vision in glaucoma patients. 
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What good is a dissertation without the meaning of life? 
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For this is man’s all.” 
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Mentat conundrum 
 
 
 
 1 
1.0  AQUEOUS HUMOR AND GLAUCOMA 
1.1 INTRODUCTION: FOR THE PAGES WE ARE ABOUT TO READ… 
The work described herein comprises a newly developed technique for the mapping of the 
conventional aqueous humor outflow system, and the measurement of aqueous humor outflow in 
the eye.  The importance of this mapping and measurement, beyond the utter Star-Trek’esque 
awesomeness of reaching into a living organ and mapping a system non-inversely, is the 
preservation of vision in persons with glaucoma.  Knowledge of where and how aqueous humor 
is leaving the eye, and how medications and invasive procedures are affecting changes to that 
outflow are of vital importance in the management of glaucoma, but are currently unavailable to 
the glaucoma specialist.   
The eye is a pressurized vessel that focuses images onto light-sensitive tissue, where 
image data is converted to electrochemical signals.1 These signals are transmitted to the brain by 
the optic nerve. Light passes through the cornea, aqueous humor, lens, and vitreous before 
reaching the light-sensitive tissues of the retina.  After passing through the retinal ganglion and 
bipolar cell layers, light reaches the photoreceptors where it is converted to an electrochemical 
signal.  This signal is transmitted to the brain via the axons of the retinal ganglion cells, which 
gather to form the optic nerve. (Figure 1).2  
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Figure 1. Gross anatomy of the eye 
The structural integrity of the eye, and therefore, relative position of its optical elements are 
maintained by the pressure within the eye.3   
Aqueous humor is a fluid produced (inflow) in the epithelial cells of the ciliary body 
(Figure 1, yellow arrows). 3  It exits the eye (outflow) through one of two paths, as will be 
described below, each with inherent resistance to outflow.3  Pressure in the eye (intraocular 
pressure, IOP) is created by the flow of aqueous humor against outflow resistance.3   It is 
possible to manipulate IOP through medical and surgical intervention by either altering the 
resistance to outflow, or reducing inflow.3   
Primary open angle glaucoma is the most common of the 4 sub-types of glaucoma, and is 
an optic neuropathy in which retinal ganglion cells die at an accelerated rate relative to that in 
healthy eyes.4  The primary risk factor for both the presence and progression of glaucoma is 
elevated IOP.4  For this reason, the goal of all therapeutic and surgical interventions in glaucoma 
is the reduction of intraocular pressure, either through the reduction of resistance to outflow, or 
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the reduction in inflow rates.  A technique to map the conventional outflow system and a 
technique to measure volumetric outflow in living eyes would be of tremendous value to 
glaucoma specialists.  The goal of the following work is the development of such a measurement 
using spectral domain optical coherence tomography (SD-OCT) three-dimensional (3D) 
imaging. 
1.2 AQUEOUS HUMOR: DYNAMICS AND FUNCTION 
1.2.1 The Source of Aqueous Humor: Functional Anatomy 
Aqueous humor is the clear liquid filling the anterior segment of the eye.5    The source of 
aqueous humor in the eye has long been thought to be the ciliary body,6 though the exact 
mechanism of production remained elusive until recently.  Aqueous humor is similar to blood 
plasma, and is a solution of Na+ and Cl- ions (approximately 150 and 130 millimolar 
respectively), though the protein content of aqueous humor is less than 1% of that of serum.7,8 
Previously thought to be an ultrafiltrate of blood9, the protein content of aqueous humor makes it 
a hyperosmotic fluid that could not be produced by filtration.10  Further, aqueous humor 
formation levels are independent of blood pressure.11,12 Metabolic inhibitors reduce the rate of 
aqueous humor production.13  If the mechanism of aqueous humor production were purely a 
filtration process, blood pressure level would alter the rate of production, and metabolic 
inhibition would not. It is generally accepted that aqueous humor formation is a more than a 
paracellular ultrafiltration process, but an ultrafiltrate of blood actively secreted by the ciliary 
epithelium through a process of transcellular transport.9     
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 Since the cornea and lens are part of the optical pathway of the eye and must be clear to 
facilitate light transmission, they are avascular tissues (Figure 2).14  Circulating aqueous humor 
takes on the roles of nutrition delivery and waste removal for the cornea and lens, as well as 
delivering neurotransmitters.14  In disease, the same circulating aqueous humor facilitates 
transport of inflammatory cells as well as drugs to the anterior ocular structures.14 
Aqueous humor flows (Yellow arrows, Figure 2) from the posterior chamber through the 
pupil into the anterior chamber.  It exits the anterior chamber via the trabecular meshwork (TM), 
into Schlemm’s canal (SC, the conventional outflow pathway) or into the supraciliary space 
(uveoscleral pathway).15 In normal healthy eyes, aqueous humor is secreted by the ciliary 
epithelium16 at a rate of 2.75 +/- 0.63 microliters per minute (µl/min) during waking hours.17  
The rate varies throughout the day, and is highest in the morning and slightly lower in the 
afternoon.  Rates during sleep drop to approximately half of those of the morning peak flow 
rate.15,17 
 
Figure 2. Anatomy of the conventional outflow pathway 
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Aqueous humor flows from the posterior chamber, around the lens, through the pupil and 
into the anterior chamber.  A temperature gradient creates convective flow streams, with aqueous 
humor rising in the warmer region near the lens, and falling in the area of the anterior chamber 
close to the cooler cornea18 (of course, these models assume a stationary open eye, and once an 
eye is blinking and changing direction of gaze in a body that is walking around, other factors 
may come into play).   
1.2.2 Aqueous Humor Outflow 
 Aqueous humor leaves the anterior chamber via one of two pathways.  The majority of 
aqueous outflow passes through the conventional pathway in adult humans, in which it passes 
through the TM, passes into SC, and flows out via a meshwork of collector channels and aqueous 
veins, which empty into episcleral veins.19-29  Pressure within the episcleral veins is 
approximately 9 millimeters of mercury (mmHg), requiring a minimal level of IOP to maintain 
the pressure gradient that drives outflow.30,31 The conventional outflow pathway is pressure-
dependent; specifically, as IOP increases, resistance to outflow increases.32 The conventional 
outflow pathway has a flow-dependent resistance of 3 to 4 mmHg per µl/min of flow, producing 
a normal IOP of approximately 16mmHg.30,31,33-36 Most of this resistance (~75%) is produced by 
flow through the TM, with the remaining resistance generated by flow distal to SC.37  Disorders 
in the conventional outflow system may result in IOP elevation, which is the greatest risk factor 
for glaucoma.38  For this reason, medications and procedures for glaucoma are designed to 
reduce resistance to outflow. 
 In the non-conventional outflow pathway, aqueous humor flows into the connective 
tissue between the muscle bundles of the ciliary body, through the suprachoroidal space, and out 
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through the sclera.39-44  Flow through the non-conventional pathway is essentially unaffected by 
IOP, though flow through this pathway decreases with age, making outflow via the conventional 
pathway increasingly important in the elderly.45,46  
1.3 GLAUCOMA 
1.3.1 Introduction 
Glaucoma is the second leading cause of irreversible blindness worldwide (after age related 
macular degeneration), affecting approximately 67 million people worldwide (2.2 million people 
in the United States) and costing the US healthcare system an estimated $2.5 billion annually.47 
The greatest risk factor for the diagnosis and progression of glaucoma is high IOP. All glaucoma 
medications and procedures are designed to reduce IOP, slowing disease progression and 
preserving vision.  Most glaucoma medications are designed to increase aqueous humor outflow, 
and most surgeries are designed to reduce resistance to outflow by enhancing or replacing exiting 
outflow pathways.  But, the effects of these medications and procedures on outflow remain 
speculative and occur without direct observation.  
1.3.2 Definition and Epidemiology 
The American Academy of Ophthalmology defines primary open angle glaucoma as “a 
progressive, chronic optic neuropathy in adults in which intraocular pressure (IOP) and other 
currently unknown factors contribute to damage, and in which, in the absence of other 
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identifiable causes, there is a characteristic acquired atrophy of the optic nerve and loss of retinal 
ganglion cells and their axons. This condition is associated with an anterior chamber angle that is 
open by gonioscopic appearance.” 4  As retinal ganglion cells are lost, the retinal nerve fiber 
layer (consisting of the axons of the retinal ganglion cells) thins, and cupping appears in the optic 
nerve head.  Retinal ganglion cell loss presents functionally as a reduced sensitivity to light 
throughout the field of vision.  
Approximately 45 million people have open-angle glaucoma worldwide.48 The 
prevalence of primary open angle glaucoma for adults 40 and older in the United States was 
estimated to be 2% in 2004,49 though it varies among ethnic groups.   The prevalence of open 
angle glaucoma in African Americans is approximately three times higher than in Caucasians in 
the United States.49-52  Open angle glaucoma is the leading cause of blindness in African 
Americans.52 
1.3.3 Intraocular Pressure and Glaucoma 
The prevalence of primary open angle glaucoma increases with IOP.35,36,51,53-56 Reducing IOP 
reduces the risk of progression of glaucoma.57-62  To that end, the reduction and control of IOP is 
the primary goal of disease management in glaucoma.4  The initial goal (target IOP) for IOP 
reduction is 25% below baseline.4 If retinal nerve fiber layer thickness, optic nerve head 
appearance, or visual fields continue to degenerate, the target IOP can be further reduced.  IOP is 
reduced either by medical therapy, or invasive procedures, which include either laser or 
incisional procedures. 
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1.3.3.1 Pharmaceutical Pressure Reduction 
 
There are currently six classes of anti-glaucoma medications, each indicated for the reduction of 
IOP.  Beta-blockers block activation of beta-adrenergic receptors, reducing IOP by decreasing 
the production of aqueous humor.63  Carbonic anhydrase inhibitors also act by decreasing 
aqueous humor production.  Unlike beta-blockers, which inhibit metabolic activity in the ciliary 
epithelium by reducing cyclic adenosine monophosphate, carbonic anhydrase inhibitors reduce 
production of bicarbonate ion, which is a critical component in the production of aqueous 
humor.63  Alpha-2 adrenergic agonists selectively activate the alpha-2 adrenergic receptors in the 
ciliary body.  As with beta-blockers, activation of the alpha-2 adrenergic receptors leads to a 
reduction of cyclic adenosine monophosphate, reducing production of aqueous humor.  Unlike 
beta-blockers, alpha-2 adrenergic agonists may also increase conventional and uveoscleral 
outflow.63   
 Muscarinic cholinergic compounds, such as pilocarpine, increase aqueous humor 
outflow.  The actual mechanism remains unclear, but it is hypothesized that they cause the 
contraction of smooth muscle within the ciliary body and iris, pulling on TM and mechanically 
opening passages within.63  Epinephrine and epinephrine analogs bind to multiple receptor 
subtypes within the eye, reducing aqueous humor production and increasing aqueous humor 
outflow; however the mechanisms of each are poorly understood.63  Finally, prostaglandins and 
their analogs reduce IOP by increasing uveoscleral outflow.63  This occurs without significantly 
altering outflow in the conventional pathway.     
A meta-analysis of the literature found that of all classes of IOP lowering medications, 
beta-blockers alone present evidence of maintaining visual fields.64 Despite the performance of 
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the class as a whole, no other individual compound had a sufficient body of work to demonstrate 
the same ability to stabilize visual fields.64  But, a more recent study suggests that alpha-agonists 
may be more effective in stabilizing visual fields than beta-blockers in POAG patients with 
normal IOP’s.65 
The actual effect of all of these classes of glaucoma medications on flow through the 
conventional outflow pathway in the living eye remains unobservable and cannot be measured.  
Neither the exact morphology of the pathway nor the flow velocities within individual eyes could 
previously be measured.  One important goal of the work described in the following chapters was 
to provide these important missing clinical measurements. 
1.3.3.2 Laser Trabeculoplasty 
There are currently two laser trabeculoplasty procedures to lower IOP; argon laser 
trabeculoplasty (ALT) and selective laser trabeculoplasty (SLT).66  Both deliver laser energy to 
the TM without ablating the tissue, producing a reduction of outflow resistance. ALT produces a 
reduction of IOP greater than 75% in eyes with no previous surgeries.4  Theories hypothesizing 
the mechanism of action resulting in the drop of outflow resistance fall into three broad 
categories: mechanical effect, metabolic effect, and cell regrowth effects.   The mechanical 
theory is based on observations of morphometric changes in tissues exposed to laser energy.67  
Tissue shrinkage in the TM may be associated with enlarged outflow pathways and reduced 
resistance.66  The biological theory proposes that the cascade of healing events triggered by the 
laser injury create a decrease in outflow resistance as a second-order effect, specifically via 
macrophage activation producing extracellular matrix and upregulation of interleukin I and 
tumor necrosis factor triggering metalloproteinase expression.66,68 The cell regrowth theory 
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proposes that newly grown cells in the TM replacing those damaged by the laser produce 
different extracellular matrix, enhancing the aqueous outflow.69  
SLT differs from ALT in that the wavelength used delivers energy selectively to the 
pigment (melanin) of the TM.  With brief pulse durations of 3ns, thermal effects in and energy 
transfer to the TM are approximately 1,000 times less that those of ALT, reducing or eliminating 
photocoagulation-induced damage.67 
All of these procedures are performed with no knowledge of the condition of the outflow 
pathway distal to the locations of laser injury.  It is possible that a foreknowledge of locations of 
patent collector channel ostia within SC would allow the surgeon more precise placement of 
laser treatments, increasing the efficacy of the procedures.  
1.3.3.3 Trabeculectomy 
Filtering surgery lowers IOP by providing an alternative outflow pathway with lower resistance 
than that of the physiological pathways.70-73  A passage through sclera into the anterior chamber 
is created, removing a small portion of the trabecular meshwork tissue.70-73  A conjunctival bleb 
is created to receive aqueous humor exiting the eye through the new passage, while providing 
some degree of outflow resistance to avoid hypotony.  Placement of the new outflow passage is 
currently made with no knowledge of the morphology of the existing physiological outflow 
pathway.  It is possible that providing the glaucoma surgeon knowledge of the patent 
conventional outflow system could allow him or her to devise surgical that spare functional 
tissues.   
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1.3.3.4 Glaucoma Implant Devices 
Trabeculectomies can fail for a number of reasons including angle closure, vitreous loss, 
fibroblast proliferation and scarring in the bleb leading to elevated outflow resistance.74-77  
Eliminating the possibility of growth into the artificial outflow pathway, and controlling the level 
of outflow resistance therein could eliminate a number of these modes of failure.  This can be 
accomplished by implanting an artificial mechanical outflow pathway, or shunt.78-80  In general, 
there are two types of shunts; those with and without valves limiting outflow.81-84  In either case, 
outflow devices are currently placed with no knowledge of the prominent outflow pathways in 
individual eyes.  If the locations of the prominent outflow pathways were known before surgery, 
it might be possible to augment and not destroy existing ostia and large collector channels.    
1.3.3.5 Non-Penetrating Glaucoma Procedures 
As stated above, 75% of resistance to outflow occurs proximal to Schlemm’s canal.37  Surgical 
procedures that penetrate into the anterior chamber (trabeculectomy and glaucoma shunts) 
bypass the source of greatest resistance.  However; those procedures also carry the risk of 
infection and other damage to interior tissues associated with penetration into the anterior 
chamber.85,86 Non-penetrating deep sclerectomy is a procedure similar to a trabeculectomy, 
except that the incision stops at the inner wall of SC, allowing anterior segment fluids to 
percolate into the newly formed outflow pathway.87,88  Canaloplasty is another non-penetrating 
procedure surgical procedure in which SC is mechanically opened by a forcing a microcatheter 
through its full circumference.   
It is possible that the efficacy of each of these procedures would improve if the surgeon 
had foreknowledge of the location of prominent collector channels and aqueous veins, and was 
able to plan the procedure so that the entry wound avoided their damage.   
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1.4 CONCLUSIONS 
Glaucoma is a blinding disease associated with elevated IOP.  Both medical and surgical 
treatments for glaucoma are designed to reduce IOP, often by reducing resistance to aqueous 
outflow.  At present, procedures are performed with no knowledge of the “outflow landscape”, 
blindly destroying areas of tissue containing outflow structures, while sparing others, all with no 
appreciation of which areas might be patent and carrying a higher volume of aqueous humor than 
others, and which are quiescent.  The ability to visualize and map the outflow pathways within 
the living eye may greatly benefit surgical planning.  If those maps of the outflow system 
contained Doppler information, the effects of glaucoma medications on aqueous humor outflow 
might be determined rapidly on a patient-by-patient basis.  Further, should the maps and Doppler 
data suggest that system capacity limits the potential for high outflow, it may be possible that 
failure of medical therapy may be bypassed completely in favor of surgical enhancement or 
replacement of the natural outflow system.  Finally, should a vast aqueous venous outflow 
network exist, but present with low velocities, SLT or ALT may be indicated, but the presence of 
a limited aqueous venous outflow network may indicate the need for either a shunt or other 
procedure creating an alternative outflow pathway.  In either case, better surgical planning would 
be possible if the aqueous humor outflow pathway could be visualized in each patient, enabling 
more personalized medicine. 
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2.0  OPTICAL COHERENCE TOMOGRAPHY 
2.1 INTRODUCTION: FROM SIMPLICITY TO REALITY 
The heart of SD-OCT technology is an optical device dating back more than 130 years. The 
Michelson interferometer splits a single beam of light into two beams with a partial mirror, each 
of those beams back-reflected by a mirror, meeting at the partial mirror, and forming an 
interference pattern in a detector (Figure 3).89  The intensity of light reaching a detector (I) is a 
function of the wavelength of the light and the offset (Δ) between the two mirrors. 
The use of a Michelson interferometry-based thickness measurements in thin films with 
micron (µ) level accuracy was described 40 years ago.90  The technique featured a low-coherence 
light source projecting into a Michelson interferometer with one moving mirror, and provided the 
description of intensity at the detector, the long-known fundamental relationships that are the 
basis of time-domain OCT.90,91 In this chapter, the relationship between the intensity of a 
monochromatic source beam and the intensity detected as a single point as a function of mirror 
offset is presented, and that relationship expanded to the special case of a wide-bandwidth source 
split by a into two paths with different intensities and detected in a spectrometer. 
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Figure 3. Michelson interferometer 
2.2 INTERFEROMETRY AND TIME DOMAIN OCT 
In the case of monochromatic light, intensity varies as the cosine of the offset between the two 
mirrors (Figure 3) and the wavelength of the light (λ, Equation 1), 
Equation 1. Monochromatic light in a Michelson interferometer 𝐼 = 4𝐼!  𝑐𝑜𝑠! 𝛿2        
with δ = (2π/λ)Δ, λ = the wavelength, and Δ equal to to the offset between the two mirrors in the 
interferometer (Figure 3).90 Expanding this description for low-coherence (wide bandwidth) light 
sources, intensity at the detector is only detectable when the offset between the two mirrors (Δ, 
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Figure 3) is near zero, eliminating the cosine term of equation 2, as a function of wavenumber 
(τ).90 
Equation 2. Broad spectrum light in an interferometer 𝑰 𝜟 =   𝟒 𝒊 𝝉𝝉𝒏𝝉𝟎 𝒄𝒐𝒔𝟐 𝝉𝜟𝟐 𝒅𝝉 
A broadband source is used in OCT because the intensity reaching the detector in 
equation 2 becomes 0 at all mirror locations away from Δ=0.  Equation 2 assumes that the partial 
mirror in Figure 3 is perfect, with no loss of light and perfect balance between the two paths.  
OCT systems use a fiber optic beam splitter in place of the partial mirror (Figure 4) with 
different intensities of light (I1 and I2) going to each optical path.  Time domain OCT has a 
moving reference mirror.  The depth of tissue in the sample arm being interrogated by the OCT 
beam is determined by the location of the moving reference mirror at the time of data 
acquisition.92    
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Figure 4. Interferometer with unbalanced beam splitter 
Accounting for differences in the optical path lengths (Δ), imbalance in the beam splitter (k1 =  
% in path 1, and k2 = % path 2), output intensity becomes:  
Equation 3. Broad spectrum light in an unbalanced interferometer 𝑰 =   𝒌𝟏𝑰𝟏 + 𝒌𝟐𝑰𝟐 +    𝒌𝟏𝑰𝟏 ∙ 𝒌𝟐𝑰𝟐 ∙ 𝐜𝐨𝐬 𝝉∆ , 
with τ = wavenumber (2π/λ).92 Recall, in the case of time domain OCT with a broadband source, 
a signal is only present at Δ≅0.  Output intensity is a function of the intensities backscattered 
from the two optical paths in time domain OCT.   
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2.3 SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY 
If the bandwidth of the light were infinitely wide, intensity at the detector would be exactly zero 
at all locations of Δ except at Δ = 0.  Finite width light sources produce a peak detector intensity 
at Δ = 0, with fall-off intensities still detectable near Δ=0.93  The relationship between light 
source bandwidth and detector intensity as a function of bandwidth (Δλ) is the same as that of the 
relationship between the width of a rect function and its Fourier transform, the sinc function.93  
Specifically, coherence length (full width half maximum, axial resolution, all the same) of a 
wide-bandwidth source is 
Equation 4. Axial resolution as a function of wavelength and bandwidth. 𝐚𝐱𝐢𝐚𝐥  𝐫𝐞𝐬𝐨𝐥𝐮𝐭𝐢𝐨𝐧 =    𝟐𝐥𝐧  (𝟐)𝝅    ∙    𝝀𝟎𝟐∆𝝀    . 
SDOCT differs from time domain OCT in the configuration of the detector, and the reference 
mirror (Figure 5). 
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Figure 5. SD-OCT has a stationary reference mirror, and spectrometer 
The interference pattern detected by SD-OCT is described by the same relationship as that of 
time domain (Equation 3).92  However, in the case of SD-OCT, the location of reflective sources 
is encoded in the wavenumber (τ).   
2.4 OCT SIGNAL PROCESSING 
The signal reaching the detector in a time domain OCT scanner consists of a brief pulse of light 
modulating in intensity (Figure 6).94  A broadband pulse of light (approximate envelope shown 
in Figure 6 as broadband spectrum) passes through reflective surfaces.  As the reference mirror 
(Figure 4) is moved through the positions incidental to the locations of the reflective sources, the 
detector signal displays two modulating fluctuations in intensity.  The only processing required 
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to recover reflectivity data needed to assemble an axial scan (A-scan) is demodulation of the 
detector signal.  The intensity of pulses in the demodulated signal is proportional to the 
reflectivity of the surfaces, and the location of the pulses is set to the position of the reference 
mirror when the pulses were detected.    
 
Figure 6. Time domain OCT from source to A-scan 
SDOCT acquires an entire A-scan in a single read of the spectrographic detector (Figure 
5).94,95  Specifically, power spectrum of the of the interference pattern contains reflectance data 
for all points within the a-scan.94,95  A linear array camera records the fringe pattern produced by 
interference of back-reflected light from the reference and sample paths (Figures 5 and 7).  When 
the light of a broadband light source (approximate envelope labeled as broadband spectrum in 
Figure 7) interferes with the light of a stable reference mirror, and the resultant fringe pattern is 
observed on a spectrographic detector, the majority of the signal consisting of the original 
envelope with a small high frequency fringe added (Figure 7). 
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Figure 7. SD-OCT from source to scan 
To process the signal, the envelope of the source is subtracted from the detector signal to isolate 
the fringe.  This signal is a function of λ.  The signal is resampled to provide equal spacing by 
wavenumber (τ, equation 3); i.e. k-space.  The real portion (power spectrum) of the inverse 
Fourier transform of the fringe pattern in k-space produces the A-scan in its entirety.94,95   
2.5 OCT IN OPHTHALMOLOGY 
Optical coherence tomography for imaging of the layers of the human retina was first described 
in 1991.91 Huang’s prototype device acquired A-scans at a rate of 2 per second, providing great 
logistical challenges in the acquisition of line scans in the retina due to eye movements, and 
negating the possibility of volumetric scans.  Subsequent time domain devices increased 
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scanning rates, and the advent of spectral domain techniques (including swept source, which is 
beyond the scope of this work) exponentially increased the rate at which A-scans were made 
(Table 1).91,96-111 The majority of the development work in OCT hardware has been conducted in 
the Jim Fujimoto’s Lincoln Laboratory at the Massachusetts Institute of Technology (MIT), or 
by graduates of MIT working at Massachusetts General Hospital (MGH), and the Ludwig 
Maximilians University (LMU) in Munich.  The exceptions are the work of Wojtkowski at the 
Institute of Physics, Nicolaus Copernicus University (NCU) and Rollins at Case Western. 
Table 1. Progress in A-scan acquisition rates with the development of OCT technology 
 
While useful for visualization of retinal pathologies such as macular holes,112-115 
drusen,116-119 and epiretinal membranes,115,120-123 assessment of RNFL thickness by OCT has 
Light Source Processing Year Author Lab A-Scan Speed 
Broadband Time Domain 1991 Huang MIT 2 Hz 
Broadband Time Domain 1993 Swanson MIT 150 Hz 
Broadband Time Domain 1996 Tearney MIT 600 Hz 
Broadband Time Domain 1998 Rollins Case Western 4 kHz 
Broadband Spectral Domain 2003 Wojtkowski NCU 15 kHz 
Broadband Spectral Domain 2003 Yun MGH 18 kHz 
Broadband Spectral Domain 2004 Nassif MGH 30 kHz 
Broadband Spectral Domain 2008 Potsaid MIT 310 kHz 
Swept Spectral Domain 1997 Goubovic MIT 2 kHz 
Swept Spectral Domain 2003 Yun MGH 15 kHz 
Swept Spectral Domain 2005 Huber MIT 20 kHz 
Swept Spectral Domain 2006 Huber MIT 230 kHz 
Swept Spectral Domain 2006 Huber LMU 370 kHz 
Swept Spectral Domain 2011 Klein LMU 1.37 MHz 
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become a standard clinical procedure in the management of glaucoma.4,112,113,124-131  OCT 
imaging of the anterior segment has been used to assess the angle;132-140 however despite having 
the advantage of being a non-invasive procedure, OCT does not have the ability to produce 
imagery of the ciliary body, an exam left to a more invasive procedure, ultrasound 
biomicroscopy.134,141,142  OCT imaging of the cornea has been shown to be useful in the 
visualization of pathologies, injuries, and for the purpose of central corneal thickness 
measurements.143-146   
 Recently OCT imaging has been used to assess the structures of the aqueous humor 
outflow system.141,147-150 While the visualization of internal bleb (see section 1.3.3.3) structure 
may be useful in determining the reason for IOP elevation after trabeculectomy, visualization of 
the aqueous humor outflow system in its entirety, from SC to scleral veins, may be possible, and 
would provide the glaucoma specialist a wealth of new information (see Chapter 1). In the next 
chapter, evidence suggesting that specific portions of the aqueous humor outflow system can 
indeed be imaged by OCT is presented. 
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3.0  IDENTIFICATION AND ASSESSMENT OF SCHLEMM’S CANAL BY SD-OCT 
3.1 INTRODUCTION: WHAT DO WE REALLY SEE?  CAN IT BE MEASURED? 
To demonstrate the ability to map the aqueous humor outflow system, identification of its 
components within SD-OCT imagery of the anterior segment is required.  In this chapter, 
evidence of the identification SC, collector channels, and aqueous vessels within 3D SD-OCT 
scans of the anterior segment is provided.  Reproducibility of measurements of those structures 
from two independent observers analyzing a single dataset is also presented. Finally, initial 
anatomical insights gleaned from the ability to measure the living and functioning SC are 
presented. 
Glaucoma is the second leading cause of blindness worldwide48, and the most important 
risk factor of glaucoma is elevated IOP.51,151 IOP in the human eye is regulated, in part, by 
aqueous outflow through the TM draining into SC and then to the collector channels (CC) which 
empty into scleral veins.5  Previous studies suggest that eyes of subjects with glaucoma have 
smaller SC’s than those of healthy individuals.152  Reduced SC size may be associated with 
elevated IOP because the size of SC is related to outflow facility.152  Past observations of 
reduced SC size and the correlation of SC size and outflow facility were obtained in cadaver 
eyes.   
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Non-invasive measurement of aqueous outflow and aqueous outflow structures including 
SC, CC, and the SC at CC ostia (SC/CC) in the human eye would provide a powerful tool for 
both clinical and basic research, and the clinical management of glaucoma.  The purpose of the 
present study was to non-invasively measure SC in living human eyes, determine the 
reproducibility of morphometric measurements within SC at collector channel ostia, and to 
compare SC area in different regions of the eye.   
3.2 METHODS 
3.2.1 Ethics Considerations 
The study was conducted in accordance to the tenets of the declaration of Helsinki, and the 
Health Insurance Portability and Accountability Act.  The institutional review board of the 
University of Pittsburgh approved the study. All subjects gave written informed consent prior to 
participation in the study. 
3.2.2 Subjects 
Healthy volunteers were recruited from the staff and faculty of the University of Pittsburgh 
Medical Center (UPMC) Eye Center.  Glaucoma subjects were recruited from patients seen on 
the glaucoma service of the UPMC Eye Center.  Schlemm’s canal and active collector channels 
were imaged by SD-OCT.  
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3.2.3 Imaging of Schlemm’s Canal 
We have developed techniques combining structural and functional SD-OCT imaging to 
accurately identify SC, to assess Doppler signals from aqueous outflow in SC, collector channels 
and scleral veins, and to make structural measurements throughout.153  SD-OCT Doppler 
measurements have been described in detail previously, and validated in an in vivo model.154 
Since successful SD-OCT imaging of SC and CC has not been accomplished previously, 
Doppler images were used in combination with structural images to confirm the location and 
identity of SC and CCs in SD-OCT limbus images in the first 5 subjects (Figure 8 A, B). Radial 
scans of the limbus and Schlemm’s canal were obtained. (Figure 8A) Reflectance and Doppler 
images appear side-by-side (Figure 8B).  Doppler shifts are graphed (Figure 8B and 8C right) 
along the red vertical line, with the blue horizontal line used to locate the measurement site 
within the structural, Doppler, and velocity graphs (Figures 8B and 8C).  The strong Doppler 
shift against the stable background (Figure 8B, center) contains laminar flow within a scleral 
vein (parabolic velocity distribution, Figure 8B right) and collector channel (smaller parabolic 
velocity distribution, Figure 8C right).  The identity of Schlemm’s canal was made by virtue of 
its connection to scleral veins via tortuous collector channels.  This connection was confirmed by 
tracing collector channels from superficial veins into the depths of the limbus to the slit-like 
structure. 
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Figure 8. SD-OCT scan location and side-by-side structure and Doppler 
CC’s appeared in the images as dark structures following tortuous paths from superficial 
veins to a deep slit-like structure (Figure 9). 
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Figure 9. Schlemm’s canal, the scleral vein into which it drains, and a collector channel 
The Doppler signature of the vein confirmed its identity as a structure containing laminar flow 
(Figure 8A).  CC’s were tracked from the vein to Schlemm’s canal, using the Doppler signature 
within the CC to confirm it as a structure containing laminar flow (Figure 8B).   
A commercially available SD-OCT optics engine (Bioptigen, Research Triangle, North 
Carolina, USA) permitted the use of a wide-bandwidth superluminescent diode array, 
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specifically a quad diode coupled source with an 870nm center wavelength and a 200nm 
bandwidth (Q870, Superlum Ltd, Dublin, Ireland). This light source had a theoretical axial 
resolution of 1.3µm in tissue; however, tissue water absorption results in a somewhat reduced 
true axial resolution in the eye. The non-isotropic raster scan consisted of 700x10 axial scans (A-
scans) sampling a 1.3mm x 0.6mm slice of tissue 2mm thick.  The raster scan was centered on a 
SC/CC, so that raster volumes contained both a SC/CC and adjacent areas of SC with no visible 
junction (Figure 9). In order to reduce background noise, each of the 700x10 A-scans was 
calculated by averaging 18 sequential raw A-scans.  Raw A-scans were acquired at a rate of 
28,000 per second. A bite bar was used to minimize fore and aft head motions during the 4.5 
second scan. In healthy subjects, SC was imaged in both eyes nasally and temporally. In 
glaucoma subjects, SC was imaged on the nasal side of the glaucomatous eye. 
3.2.4 Image Processing 
Each of the 10 B-scans (consisting of 700 averaged A-scans) was resampled to a 1:1 
aspect ratio, and measurements were obtained using ImageJ (ImageJ 1.40g, 
http://rsb.info.nih.gov/ij/).  Contrast and magnification were subjectively adjusted to maximize 
visualization of SC, which was manually traced using the “freehand selection tool”.  (Figure 10) 
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Figure 10. Schlemm’s canal is visible adjacent to a collector channel ostium (A) and at the ostium (B). 
Measurements were made in both locations by increasing contrast (C) and magnification (D). Schlemm’s canal was 
then outlined using the freehand tool in ImageJ (E).  When outlined, ImageJ automatically measured the enclosed 
area, presenting results in square micrometers in calibrated images. 
!" #" $"
%" &"
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3.2.5 Reproducibility of Morphometric Measurements of Schlemm’s Canal 
In a subset of healthy subjects, 1 volumetric scan of SC was measured 3 times by two 
independent observers. Observers were instructed to locate the SC/CC junction within the raster 
scan, and select a cross-sectional image of SC within a few frames of the junction, no more than 
3 frames (180 µm) from the SC/CC.  To estimate bias (relative systematic difference) and 
imprecision (random difference) between two observers, a latent variable measurement error 
model was fitted to the six repeated measurements (3 from each observer). This model included 
parameters of observer, and measurement number (measurement 1, 2, and 3).   
3.2.6 Comparison of Schlemm’s Canal Area in Different Regions of the Eye 
The effects of scan location within the eye (temporal versus nasal) and scan location 
within SC (on versus off SC/CC) were analyzed by a linear mixed effects model.   SC cross-
sectional areas were compared between healthy and glaucoma subjects by Mann-Whitney Rank 
U-test.  A p value less than 0.05 was considered statistically significant.   
3.3 RESULTS 
3.3.1 Imaging of Schlemm’s Canal in Living Human Eyes 
 SC was successfully identified and imaged in every normal healthy subject in whom 
imaging was attempted.  Specifically, SC was located nasally and temporally in both eyes in 17 
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female and 4 male healthy subjects (34 ± 9 years, range 24 - 49).  Three glaucoma subjects were 
imaged (57 ± 6 years, range 52 - 63).  SC and collector channels were successfully located in two 
of the glaucoma subjects.  SC and collector channels were not found in the third subject, who 
had an implanted glaucoma drainage device.   
3.3.2 Reproducibility of Morphometric Measurements of Schlemm’s Canal 
A randomly selected subset of 12 healthy subjects was included in the reproducibility and 
location comparison studies.  Each observer made three measurements of Schlemm’s canal 
cross-sectional area on and adjacent to a collector channel ostia.  The latent variable model 
produced calibration equations relating the measurements of the two observers.  No bias between 
repeats within observers was observed.  A model without bias was fitted. A coefficient of 
variability (CoV) of 11.4% was calculated from quantification of imprecision. 
3.3.3 Comparison of Schlemm’s Canal Area in Different Regions of the Eye 
Schlemm’s canal cross-sectional area (Table 2, mean (standard deviation)) was measured 
at visible collector channel junctions, and adjacent to those junctions by two independent 
observers.  Average measurements from the subjects included in the reproducibility study are 
listed in Table 2. 
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Table 2. Schlemm’s Canal area measurements in healthy eyes (µm2) 
 
Schlemm’s Canal at Collector Channel Ostium* Schlemm’s Canal near Collector Channel Ostium 
Nasal Temporal Combined Nasal Temporal Combined 
OD 
Observer 1 13,797 (6,770) 10,390 (4,846) 12,605 (6,261) 7,998 (3,207) 4,964 (1,503) 7,027 (3,099) 
Observer 2 12,280 (2,894) 11,236 (2,510) 11,915 (2,746) 7,446 (1,658) 6,080 (914) 7,009 (1,580) 
Combined 13,039 (5,160) 10,813 (3,744) 12,260 (4,785) 7,722 (2,529) 5,523 (1,333) 7,018 (2,345) 
OS 
Observer 1 13,738 (4,177) 12,485 (5,176) 13,768 (5,512) 8,739 (3,068) 6,411 (3,676) 7,721 (3,481) 
Observer 2 11,785 (1,939) 12,073 (2,153) 12,033 (2,427) 7,706 (2,190) 7,028 (1,719) 7,385 (1,958) 
Combined 12,762 (3,342) 12,279 (3,815) 12,593 (3,474) 8,276 (2,679) 6,720 (2,802) 7,557 (3,255) 
Combined 
Observer 1 13,768 (5,512) 11,438 (4,946) 12,592 (5,376) 8,310 (3,121) 5,730 (2,881) 7,336 (3,255) 
Observer 2 12,033 (2,472) 11,654 (2,288) 11,900 (2,356) 7,542 (1,835) 6,582 (1,443) 7,171 (1,742) 
Combined 12,900 (4,306) 11,546 (3,782) 12,426 (4,158) 7,933 (2,577) 6,156 (2,285) 7,254 (2,605) 
*Mean (SD) 
Nasal SC areas were significantly larger than temporal SC areas (p = 0.009).  Cross-
sectional SC areas were significantly greater at junction sites than adjacent to those sites, 12,426 
± 4,158µm2 versus 7,254 ± 2,605µm2 respectively (mean ± SD; p < 0.0001).  In the two 
glaucomatous eyes, cross-sectional SC areas on and off collector channel junctions were 6,025 ± 
1,909µm2 and 3,725 ± 742µm2 respectively.  SC areas were statistically significantly smaller in 
glaucoma patients than in normal subjects, whether pooled (p=0.006), or grouped by 
measurements on SC/CC (p=0.039) or off SC/CC (p=0.031).   
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3.4 DISCUSSION 
3.4.1 Summary of Findings 
We found that a combination of signal averaging and high axial resolution enables the 
location of superficial vessels in the limbus and the collector channels that drain into them, 
which can be traced, either in live acquisition mode or in 3D data blocks, to locate SC.   When 
located, the cross-sectional area of SC can be reproducibly measured.  The cross-sectional area 
of SC was larger at junctions with active collector channels; determination of activity was based 
on the presence of a Doppler signal within. SC was significantly smaller in the two patients with 
glaucoma compared to the healthy subjects. In one patient with a glaucoma drainage device, SC 
and CC could not be located. 
3.4.2 Reproducibility 
A latent variable model using measurements from two observers computed imprecision 
associated with the measurement process.  Each observer measured a single set of images 3 
times.  Since variability changed with level, data were log transformed, and SD estimated in log-
space.  In order to account for the change in SD with level, SD was normalized to level, and the 
resulting CoV was 11.4%. This value estimates measurement imprecision, and is needed when 
calculating statistical power during the design of clinical experiments.  
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3.4.3 In-Vivo Versus In-Vitro Analysis of Schlemm’s Canal 
SC areas have been measured after fixation in several histological studies.  Hulzen et al 
examined the effect of perfusion pressure on SC area, measuring immersion fixed versus 
perfusion fixed at 15 mmHg.155  Wild et al. compared viscoelastic substances in 
viscocanalostomy procedures, and their study included a control group.156  In the Wild study, SC 
area was measured at the location of a deep flap penetrating to SC, and 6m away from the flap.  
Using their published data, we calculated the overall mean and standard deviation of the data as 
presented, and used those values to calculate the 95% confidence interval, which was calculated 
as mean ± 1.96*standard deviation.  Histological values then increased to account for 15% tissue 
shrinkage associated with fixation.157 (Table 3) 
Table 3. Published values of Schlemm’s canal area 
 Published Values Adjusted Values 
Author: Condition Lower Limit Upper Limit Lower Limit Upper Limit 
Johnson: IM-Fixed 825 8,138 971 9,574 
Johnson: PP-Fixed 176 5,715 207 6,724 
Wild: at flap 858 7,762 1,009 9,132 
Wild: 6mm from flap 1,202 7,310 1,414 8,600 
 
 Considering SC area measurements away from CC ostia, all temporal data fell within the 
95% confidence interval for all normative data adjusted for shrinkage, except for observer 2’s 
OS and combined measurements.  All nasal and temporal SC area measurements off of CC ostia 
fell within immersion fixed 95% confidence intervals, with the lone exception of observer 1’s 
OS nasal measurement.  None of the measurements obtained at CC ostia were within the 95% 
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confidence intervals regardless of fixation method.  Overall, the magnitudes of SC area 
measurements in the present study are in good agreement with published values, after adjusting 
for shrinkage, though tended to be toward the high end of the 95% confidence interval.  This 
suggests the possibility that some statistically insignificant difference between the present in-
vivo measurements and published histological measurements exists.  Such a systematic 
difference could result from an underestimation of the effects of tissue shrinkage, some 
systematic difference between study populations in this and the published work, or some small 
error in the calibration of the SD-OCT images.   
3.4.4 Ostia Versus Adjacent Regions of Schlemm’s Canal 
 If measurements are made exclusively on ostia, they are statistically significantly larger 
than published values since they are not contained within the adjusted 95% confidence intervals.  
The broadness of the confidence intervals for published data suggests that histological 
assessment was performed on a wide range of SC presentations.  It is unknown whether 
histological measurements obtained exclusively at ostia would agree with data in the present 
study. 
 After ongoing validation studies are complete, this non-invasive measurement of aqueous 
outflow may find a number of immediate applications.  The most obvious is basic research of the 
physiology of aqueous outflow and the pathophysiology of aqueous outflow in glaucoma.  The 
present findings in two glaucoma subjects showed that the structures involved in aqueous 
outflow are narrow in vivo, in agreement with prior histological findings.152 Other applications 
will include investigations of the impact of glaucoma medications and treatments on the 
modulation of aqueous outflow in both healthy and glaucomatous eyes.  Eventually, aqueous 
 37 
outflow measurements may also be useful in pre-surgical planning.  The utility of aqueous 
outflow imaging for pre-surgical planning may vary with procedure.  If a procedure is designed 
to facilitate aqueous outflow from the TM into SC, then it is suggested (but remains to be 
demonstrated) that optimal outcomes will occur when flow from the TM is increased in a region 
adjacent to a large and active SC ostium 
3.4.5 Nasal Versus Temporal Schlemm’s Canal Areas 
 SC was found to be statistically significantly larger on the nasal side compared to the 
temporal.  This finding was consistent whether on or off of a SC/CC.  This may suggest 
preferential nasal drainage in the normal healthy eye, and may suggest that interventions 
designed to enhance outflow on the nasal side may be preferred.  Further study is required.   
 In the patient with a glaucoma drainage device, neither CCs nor SC were visualized.  It is 
possible that the natural outflow system collapsed beyond the limits of resolution employed after 
being replaced by an alternate outflow pathway.   
3.4.6 Limitations of the Present Study 
There are several limitations to the present study.  First, and foremost, a single scan was obtained 
from each area and measured repeatedly.  The coefficient of variability of 11% only represents 
the variability of the measurement process, and provides no information on the actual variability 
of SC.  Without a knowledge of SC cross-sectional area variability within SC and over time, the 
findings in this study cannot be generalized beyond the constraints of this study design; 
specifically, SC cross-sectional area at an ostium is larger than the cross-sectional area of SC 
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immediately adjacent to the ostium.  The measurement technique functions with adequate 
reproducibility, allowing further studies of the reproducibility of SC size in repeated 
measurements.   
Samples of SC away from SC/CC were limited to locations within 180 µm (3 adjacent 
frames) of a visible junction.  As a result, only a small sample of SC was imaged and analyzed in 
this study.  Future work must include a comprehensive 360° survey of SC.  Such a survey will be 
difficult to accomplish in humans for several reasons.  First, each scan volume was acquired in 
4.5 seconds; each individual frame requiring 0.45 seconds. Eye movements may be minimized 
with the use of a bite bar; however, movements between scans make it extremely difficult to 
obtain a series of adjacent raster scans at known locations.  With each scan volume traversing 
only 0.6 mm of SC in 4.5 seconds, under ideal conditions, imaging of the SC all around the eye 
would require 279 seconds (4.65 minutes) of scan time.  Second, despite being located in all eyes 
without shunts, each eye had many regions in which shadowing from superficial blood vessels 
obscured SC and the CC’s (Figure 11). 
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Figure 11. Shadows from superficial blood vessels often obscure part or all of Schlemm’s canal. 
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Shadowing did not prevent the identification and measurement of SC/CC junctions, as 
locations with sufficiently few shadows were present in all eyes (usually the 3 or 9 o’clock nasal 
location).  However; the combination of blood vessel shadowing and scan time makes the 
completion of a comprehensive map of all collector channel junctions and all of SC unlikely.  It 
is possible that longer wavelength systems may be more robust to shadow artifact, but it is 
unknown whether longer wavelengths will have sufficient axial resolution to image SC, nor 
would such a system address the limitation of scan time.  Axial resolution is inversely 
proportional to center wavelength, and as longer wavelengths are used, resolution suffers. The 
optimal wavelength for SC imaging and measurement may differ, and is yet to be determined.  
Another limitation of the study is the small number of glaucoma subjects.  Caution should be 
used in interpretation of results drawn from the small sample, however the observed differences 
are of interest, and our pilot results emphasize the need for further investigation. 
In the present study, a simple subjective method of quality control was used to detect eye 
movements.  Since the scan set consisted of 10 B-scans obtained approximately in a single 
location, it was simple to page rapidly between B-scans and compare the appearance of the 
anterior corneal surface.  Scans containing apparent eye movements were not used for analysis.  
Generally speaking, no technological advance can be trusted to completely eliminate eye 
movement artifacts from OCT or any other scanning ophthalmic imaging technique.  Some 
method of quality control or image validation will always be needed. That being said, it is 
possible that reduced scan times in future OCT systems will lessen the deleterious effects of eye 
movements.  Swept-source technology has increased the A-scan rate to 1.37 MHz in a prototype 
system.95 Applied to the scan protocol used in the present study, a 1.37 MHz scan rate would 
reduce the B-scan acquisition time from 0.45 to only 0.01 seconds.  Visual inspection for eye 
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movements between slices will always be necessary when images are being used to characterize 
morphology, but increased scan speeds will likely reduce the number of frames discarded due to 
eye movements. 
3.4.7 Conclusions 
SC and the aqueous outflow system can be non-invasively imaged and Doppler shifts 
quantified in the living human eye. These measurements will be useful in physiological studies 
of aqueous outflow, and clinically useful for the determination of the impact of glaucoma 
therapies on IOP as well as in pre-surgical planning. 
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4.0  VARIABILITY OF SCHLEMM’S CANAL CROSS-SECTIONAL AREA ALONG 
ITS CIRCUMFERENCE 
4.1 INTRODUCTION: SUBJECTIVE OBSERVATIONS AND CONVENTION 
In the previous chapter, the ability to reproducibly measure SC cross-sectional area was 
established.  In that study, two independent observers measured two slices from a single 3D scan 
repeatedly.  Further, a definite landmark (a collector channel ostium) was used to ensure that 
both observers measured the same location.  These data do not address the spatial variability 
characteristic of SC along its circumferential length.  In February 2011, while reviewing SD-
OCT volumetric scans and SC histology slides side by side together with Dr. Haiyan Gong, she 
noted that she has observed large variations in SC size, shape, and location in sequential 
histology sections.  While informally known and accepted in the research community, that 
characteristic of SC variability has not been reported in the literature.  The advent of volumetric 
scanning of the outflow system with SD-OCT allows quantification of SC cross-sectional area in 
sequential scans, and more importantly, allows the quantification of change in area along its 
length.  The purpose of this study was to quantify changes in SC cross-sectional area in 
sequential SD-OCT scans. 
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4.2 METHODS 
4.2.1 Ethical Considerations 
The study was conducted in accordance with the tenets of the Declaration of Helsinki and the 
Health Insurance Portability and Accountability Act. The institutional review board of the 
University of Pittsburgh approved the study. All subjects before participation gave written 
informed consent. 
4.2.2 Study Design 
Six healthy volunteers were recruited from the staff and faculty of the UPMC Eye Center. SD-
OCT images of the limbus were obtained from the nasal and temporal quadrants.  Images were 
4x4mm, with a slab thickness of 2mm.  SC was located within the images.  Of the 4mm length of 
SC contained in 128 b-scans, a 1mm sequence of 32 sequential scans in which SC was clearly 
visible without shadow or other artifacts was identified.  Slice to slice differences in SC cross-
sectional area in a 1mm sample length were measured. 
4.2.3 Imaging of SC  
SD-OCT (Cirrus HD-OCT; Carl Zeiss Meditec, Inc., Dublin, CA) was used to image SC.  512 x 
1024 x 128 samples were acquired in a 4 x 2 x 4 mm volume of the limbus. The acquisition rate 
was 27,000 A-scans per second. Moving chin and forehead rests were used to center the eye in 
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the image frame, and then verbal commands were used to position the desired region of the 
limbus in the image.  B-scans (or slices) were separated by 31.25µm.  Scan time was 2 seconds.   
4.2.4 Image Processing and SC Visualization 
Images were pre-processed with a 3x3x3 kernel-size averaging filter using software of our own 
design (Listed in Appendix A). Images were then blurred and contrast enhanced using an 
automatic local contrast enhancement by adaptive histogram filter, and then subjectively by 
manual contrast and brightness adjustment in Fiji (ImageJ 1.45q, NIH, http:imagej.nih.gov/ij). 
SC was manually circled as in the previous chapter, and area was measured.  A second 
independent observer reviewed the images with and without outlines to confirm accuracy.   
Individual slices were excluded when SC was not visible for any of the following 
reasons: 1) SC was present and visible but closed, 2) SC was not in the imaged field of view, or 
3) SC was obstructed by poor image quality or shadowing. The quadrant was excluded if all 32 
consecutive slice sequences contained 12 or more excluded slices.  
4.2.5 Statistics 
The absolute difference between sequential slices was calculated.  If a slice was excluded, the 
gap was not included in any difference calculation.  
 45 
4.3 RESULTS 
4.3.1 Subjects 
Six healthy eyes (3 right (OD), 3 left (OS)) from six volunteer subjects (4 male, 2 female; age 
range: 25-53 years) were recruited for the study. 
4.3.2 Imaging of SC 
For each of the 6 eyes, both nasal and temporal quadrant image series were taken, giving 12 total 
image series. Of the 12 image series, 10 presented as complete and containing visible SC 
throughout the entire 1mm (32 slices) sample length.  Of the 2 series with incomplete quadrants, 
1 (Subject 2, temporal) was missing 5 slices (remaining 27 of 32 slices used), while the second 
(Subject 5, nasal) was excluded based upon the stack exclusion criteria.  
4.3.3 SC Variability 
The average cross-sectional area and standard deviation using all eleven stacks was 
10546.96µm2 and 4200.95µm2, respectively.  The average slice-to-slice change in SC cross-
sectional area across all stacks was 2875.54µm2 ± 2019.65 µm2 (mean ± standard deviation).  
This represents an average change of SC cross-sectional area of 27.27% in within a 31.25µm 
distance along its circumference, or a spatial rate of change in SC cross-sectional area of ± 
93µm2/µm. Projecting these results to a histological series of 5µm sections, each section would 
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be expected to differ in SC cross-sectional area by a difference of 465µm2. Table 4 shows the 
average and standard deviation of slice-to-slice cross-sectional area change for each stack. 
Table 4. Slice to slice variation in Schlemm’s Canal cross-sectional area (CSA) 
 
Figure 12 provides a sample of 10 sequential frames of SC (radial sections, bottom) in a typical 
region of nasal limbus (coronal section, top).  SC is nearly closed in frame 5, open at two 
Subject( Region(
Average(
CSA((std.(
deviation)(
[μm2](
CoVariance(
[%](
Slice@to@
Slice(
CSAChange(
(std.(
deviation)(
[μm2](
1( temporal(
6566.05(
(1764.99)( 27.09(
1660.75(
(1294.87)(
1( nasal(
4438.40(
(1836.26)( 41.70(
1143.92(
(884.16)(
2( temporal(
3162.53(
(1209.65)( 38.60(
752.38(
(854.01)(
2( nasal(
9948.73(
(4450.19)( 45.08(
3161.03(
(3086.15)(
3( temporal(
16195.30(
(5567.89)( 34.65(
3573.51(
(2315.94)(
3( nasal(
14074.33(
(4922.24)( 35.25(
2899.17(
(1895.58)(
4( temporal(
13256.07(
(5553.59)( 42.22(
2955.28(
(2591.00)(
4( nasal(
21056.18(
(8259.66)( 39.53(
6002.12(
(4463.55)(
5( temporal(
9962.08(
(4430.76)( 44.82(
2875.54(
(2019.65)(
6( temporal(
10055.54(
(5107.41)( 51.19(
2978.91(
(3379.81)(
6( nasal(
7301.33(
(3107.83)( 42.90(
2264.21(
(1779.77)(
Average( ((
10546.96(
(4200.95)(
40.74(
(6.40)(
2751.53(
(2233.14)(
(
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locations in frame 6, slit-like in frames 4, 6, and 7, open in frames 10 and 1, at an ostium in 
frames 2 and 3, and all of this occurring within 281µm SC’s circumferential length. 
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4.4 DISCUSSION 
4.4.1 Summary of Findings 
In the present study, we found that the average change in SC cross-sectional area in sequential 
slices separated by 31.25µm was 2,876µm2.  With an observed average cross-sectional area of 
10,547µm2, the coefficient of variance for SC cross-sectional area slice to slice measurement is 
over 40%. 
4.4.2 The Impact of Variability on SC Characterization 
Given the mean coefficient of variation to 40.74%, a sample of 500 slices would be needed to 
estimate the average SC cross-sectional area within a 3% margin of error at a 90% power. For 
perspective, assuming a 12mm limbus diameter, sectioning SC in 1µm slices would yield 
approximately 37,700 samples.  The SD-OCT scanning protocol used in this study acquires 128 
B-scans in a 4mm length.  Assuming the ability to rotate the scans (the current generation of 
scanner cannot rotate scans), this protocol would yield 1,206 B-scans.  Nearly half of the scans in 
the OCT protocol would be required to accurately assess SC cross-sectional area.  An alternative 
technique is required. 
4.4.3 A Possible Solution 
Faced with a similar situation in blood flow measurements, the distribution of flow values was 
used to describe a flow field in lieu of a single mean value.158  We found that a single average 
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used to describe non-normally distributed data reduced sensitivity to differences, whereas using 
quartile and 10 and 90 percent values in the histogram (a rank-order approach) of all 
measurements allowed discernment between health and disease.158   
In the previous chapter, a single measurement was used to compare two distinct locations 
on SC within a single scan; specifically, the cross-sectional area at an ostium and immediately 
adjacent to one.  In this context, single measurements were meaningful, since no attempt to 
characterize SC as a whole was being made.  The challenge here is to create a technique to 
characterize the size of SC in cross-sectional sections.  Beyond the need for accuracy, there is 
also a need to determine those parameters characterizing SC size and morphology that are best 
related to aqueous humor outflow.  It is possible that the entire need of cross-sectional 
measurements may be circumvented if total SC volume is found to be more pertinent for the 
characterization of aqueous humor outflow.  Future studies examining the relationship between 
SC volume and descriptions of cross-sectional area and are needed. 
4.4.4 Conclusion 
In conclusion, cross-sectional area fluctuates greatly within short circumferential lengths of SC.  
Because of this, single or small numbers of measurements of cross-sectional area may provide a 
limited characterization of SC.  An alternative method may be required to describe the size of 
SC. 
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5.0  REPRODUCIBILITY OF SCHLEM’S CANAL CROSS-SECTIONAL AREA 
ASSESSMENT IN REPEATED SCANS 
5.1 INTRODUCTION: CAN IT BE DONE AT ALL? 
In Chapter 3, the variability of a SC measurement technique was demonstrated to be 
approximately 11%; however, the in previous chapter, application of that same measurement 
technique to a sequence of radial scans of the limbus found that SC cross-sectional area within a 
single volumetric scan changes radically.  SC scans separated by only 31.25µm have an average 
change in cross-sectional area of 2875.54µm2. The large changes in SC cross-sectional area that 
occur within small changes in location call into question whether it is physically possible to 
return repeatedly to the same location of SC with sufficient precision for stable and reproducible 
measurements of cross-sectional area.  The purpose of the present study was to quantify the 
variability of repeated measurement of SC cross-sectional area and measurement technique in a 
series of SD-OCT volumetric scans. 
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5.2 METHODS 
5.2.1 Ethical Considerations 
The study was conducted in accordance with the tenets of the Declaration of Helsinki and the 
Health Insurance Portability and Accountability Act. The institutional review board of the 
University of Pittsburgh approved the study. All subjects before participation gave written 
informed consent. 
5.2.2 Study Design 
Ten healthy volunteers were recruited from the staff and faculty of the UPMC Eye 
Center. Three SD-OCT scans of the limbus were obtained from the nasal quadrant of the right 
eye at a single visit.  Images were 4x4mm, with a slab thickness of 2mm.  The analysis 
comprised two parts:  1: SC was identified and, using surrounding collector channels and 
vascular landmarks, a single location was identified and measured by two observers in each of 
the three scans.  SC cross-sectional area was measured independently at that location by the same 
two observers.  Observers each subjectively manually adjusted contrast to optimize visualization 
of SC and made cross-sectional measurements as described in Chapter 3.  Images were then 
closed without saving and re-opened, and an automated processing routine performed to adjust 
contrast.  SC was then re-measured with the automatically processed images (code provided in 
Appendix 2).  2: A single observer measured all 31 sequential B-scans centered on the previously 
identified B-scan.  Measurements were performed after automatic contrast enhancement. 
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5.2.3 Imaging of SC  
SD-OCT (Cirrus HD-OCT; Carl Zeiss Meditec, Inc., Dublin, CA) was used to image SC.  512 x 
1024 x 128 samples were acquired in a 4 x 2 x 4 mm volume of the limbus. The acquisition rate 
was 27,000 A-scans per second. Moving chin and forehead rests were used to center the eye in 
the image frame, and then verbal commands were used to position the desired region of the 
limbus in the image. Scan time was 2 seconds.   
5.2.4 Image Processing and SC Visualization 
Images were pre-processed with a 3x3x3 kernel-size averaging filter using software of 
our own design. For part 1 (subjective contrast enhancement), contrast and brightness were 
manually adjusted to optimize visualization of SC.  Pre-processed images were then re-opened, 
and an automatic processing routine (provided in Appendix B) in which images were blurred and 
contrast enhanced using by local contrast enhancement by adaptive histogram filtering Fiji 
(ImageJ 1.45q, NIH, http:imagej.nih.gov/ij).  A final manual adjustment of contrast and 
brightness was permitted. SC was manually circled as in the previous chapters, and area was 
measured.  
5.2.5 Statistics 
In part 1 (one measurement manually and automatically processed, analyzed by two observers), 
differences in area measurements between observers and automation were compared by analysis 
of variance (ANOVA).  The coefficient of variability was calculated for each subject’s set of 3 
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scans for each observer for both manual and automated image processing.  In part 2, the 
coefficient of variation for the mean was calculated for each subject.  Since each scan produced 
32 area measurements, the quartiles for each scan were recorded, and coefficients of variability 
calculated for the quartiles.  
5.3 RESULTS 
5.3.1 Part 1: Observers and Automation 
When contrast was adjusted manually, there was a statistically significant difference between SC 
cross-sectional area measurements between observers 1 and 2 (9,387±3,597µm2 and 
13,739±8,781µm2 respectively; mean±SD, p=0.017).  When contrast was adjusted automatically, 
the difference between SC cross-sectional area measurements was eliminated (9,296±3,908µm2 
and 9,845±4,333µm2; p=0.615).  Post-hoc analysis revealed that there was a significant 
difference in pooled SC cross-sectional area between manually and automated adjustment 
(p=0.0136), but when separated by observer, only observer 2 presented with a difference in 
cross-sectional area measurements between manually and automated processing (p=0.0017) 
while there was no difference between the two for observer 1 (p=0.8856).   Interestingly, the 
coefficient of variability actually increased for both observers with automated contrast 
enhancement compared to manual adjustment (Table 5). 
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Table 5. Automated contrast enhancement increases measurement variability 
 
5.3.2 Part 2: 31 Samples per Image 
When 31 samples of SC cross-sectional area were taken from each image (representing 1mm of 
circumferential arc length in SC) overall mean SC cross-sectional area was 4046±1055µm2.  The 
average coefficient of variability for the estimate of mean cross-sectional area across all subjects 
was 26.0%.  The 25th, 50th, and 75th percentile measurements of SC cross-sectional area were 
2911±965, 3901±1100, and 5048±1207µm2 respectively.  The coefficients of variability for the 
25th, 50th, and 75th percentile measurements of SC cross-sectional area were 34.6%, 28.1%, and 
24.0% respectively.   
5.4 DISCUSSION 
The data in the present study strongly suggest that the subjective identification of a location for 
measurement of SC cross-sectional area is highly biased toward unrepresentatively high values.  
The mean±SD and median±SD SC cross-sectional area measurements were 4046±1055µm2 and 
3901±1100 µm2 respectively when a 1mm circumferential arc length of SC was sampled.  When 
the observers identified an area for measurement from the slices within the 3D dataset based on 
the ability to locate the same position in each of the three scans within a subject, the means±SD 
for the two observers of those measurements were 9387±3597µm2 and 13,739±8781µm2 for 
 Manual Adjustment Automated Adjustment 
Observer 1 13.5% 17.6% 
Observer 2 15.5% 19.5% 
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manually adjusted contrast, and 9296±3908µm2 and 9845±4333µm2 with automated contrast 
adjustment.  These estimates of cross-sectional area are more than two times larger than the 
either the mean or median estimates of SC size.  Indeed, they are approximately twice as large as 
the 75th percentile value of 5048±1207µm2!  It appears that, despite the effort to locate a 
“representative” image of SC, observers will choose a region that represents an outlier with 
respect to actual SC cross-sectional area.  This means that if the purpose of a study is to honestly 
estimate SC area, a 3D scan containing numerous samplings is necessary to avoid bias toward 
unrepresentatively high values.   
Interestingly, the coefficients of variability in measurements of area decreased steadily as 
size increased.  Note steady decline of coefficient of variability as quartiles increase with values 
of 34.6%, 28.1%, and 24.0%, respectively.  Also, the coefficient of variability for the mean was 
26.0%; similar to that of the median.  This may be due to increasing ease of measurement of 
progressively larger and larger structures.  The coefficient of variability of the subjectively 
located behemoth region of SC with an area twice that of the average had a scan to scan 
coefficient of variability of 13.5% and 15.5% for the two observers; scarcely larger than the 
11.4% found for the measurement of identical images in Chapter 3.  Indeed, these data support 
the ability to return to a single location of SC for non-invasive longitudinal quantification of 
cross-sectional area based on the subjective appearance and measurement agreement between 
three sequential scans; however, values for cross-sectional area for an average size of SC have an 
associated coefficient of variability of 26%, while measurements in regions that are 
unrepresentatively large have inherent variability of a more acceptable level.  This creates a 
conundrum.  If serial sections within a 3D scan volume are analyzed, the experiment will have 
greater sensitivity to the detection of change using measurements of larger cross-sectional areas; 
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perhaps using the 75th percentile value.  However, these values may not be representative of SC 
overall.  If an investigator anticipates that only the smallest regions of SC will be changed by an 
experimental perturbation, then the 25th percentile value may be the best parameter to use, but 
that change may be more difficult to detect since the 25th percentile value had an associated 
coefficient of variability of nearly 35%.  If detection of ANY change is desired, regardless of 
location, then a single measurement at a user selected region is sufficient, as this will be most 
sensitive to detectable change by virtue of the much lower associated measurement variability of 
~14%.  These data are vital in the planning of an experiment, and an educated guess as to the 
location where change is expected is needed if anticipated measurement variability of less than 
35% is desired.   
It was also interesting that automation, while reducing differences between observers, 
increased measurement variability for both.  It appears that subjective control of the appearance 
of the image improves performance as suggested by lower measurement variability.  This brings 
into question the effects of various levels of image processing on SC cross-sectional area 
measurements.  In Figure 13, a single histological image of SC from a human cadaveric eye is 
processed in two ways; the top emphasizing the difference between the tissue types near SC and 
the surrounding regions, and the bottom emphasizing the open spaces within the region of SC.  
The yellow outline demonstrates two different interpretations of SC cross-sectional area that 
could be made from this single histological slice. 
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 Similarly, the processing of OCT images can result in similar alternative interpretations.  
A single OCT image (Figure 14) has been processed in two ways; the upper emphasizing the 
region of SC, and the lower showing the open regions among the septa within SC.  Note that the 
difference in processing results in an enormous difference in measured SC area; a difference of 
over 10,000 µm2!  As with the identification of measurement location discussed previously, 
defining the purpose of the measurement is necessary before designating an imaging strategy.  If 
the purpose is to quantify the available empty space for the passage of aqueous humor, then the 
processing strategy on the bottom is appropriate.  If the purpose is to assess the region of SC 
regardless of internal septa, the top processing strategy is appropriate.  Based on previously 
published values of SC cross-sectional area, either the upper strategy has been employed 
previously, or the bias discussed above also plays a roll in histological studies.155,149,156   
5.4.1 Conclusion 
In conclusion, the best processing and analysis strategy for the measurement of SC cross-
sectional area depends on goal of the investigation.  The best strategy for a measurement with the 
lowest variability is a single assessment at a user-identified location, with the understanding that 
the result will be an area measurement that grossly over-estimates actual SC size.  The most 
representative measurement is obtained by measuring a sequence of samples through a 
circumferential arc of SC, with the understanding that the variability will be twice that of the 
single measurement.   
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6.0  ELEVATED IOP REDUCES THE CROSS-SECTIONAL AREA OF SC IN 
HUMAN EYES 
6.1 INTRODUCTION: CLINICAL USE OF SD-OCT SC IMAGES IN 2D 
Glaucoma is the second leading cause of irreversible blindness worldwide.159  The greatest risk 
factor for the presence and progression of glaucoma is elevated IOP.50,51,57,160,161 The balance 
between aqueous humor production and outflow regulates IOP,162-165  though the relationship 
between IOP and the morphology of the primary aqueous humor outflow pathways remains 
unclear.   
It is known that that herniation of the inner wall of SC occurs with IOP elevation in a 
bovine eye perfusion model.166,167 The precise effect of IOP elevation in the human eye on SC 
morphology remains unknown, though the animal model predicts that the inner wall will move 
into the SC space as IOP increases.  In the previous chapter, the ability to assess SC cross-
sectional area with sufficiently low measurement variability was demonstrated.  The purpose of 
the present study was to observe SC morphology non-invasively in a human cadaveric eye 
perfusion model at two different levels of IOP.  
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6.2 METHODS 
6.2.1 Ethical Consideration 
Two human cadaver eyes with no history of eye disease, trauma or ocular surgery other than 
cataract were obtained from the Center for Organ Recovery and Education (Pittsburgh, PA). The 
Committee for Oversight of Research Involving the Dead of the University of Pittsburgh 
approved the study. Consent for the use of all tissues for research was obtained by the individual 
agency responsible for harvesting and supplying the tissue.   
6.2.2 Tissue 
 The perfusion model and imaging technique have been described in detail previously.150  
Briefly, warmed eyes were placed in a custom-made fixation mount.  Eyes were irrigated with 
40oC saline to prevent dehydration and to minimize cooling during imaging.  A 27-gauge needle 
was inserted into the peripheral cornea, with the needle tip passing through the pupil and 
positioned posterior to the iris and anterior to the lens. Barany’s mock aqueous humor165 was 
used to perfuse the eyes. After 20 minutes of perfusion for stabilization, the rate of perfusion was 
determined by recording the weight of the mock aqueous humor in a reservoir in real time.  
Immediately after completion of the perfusion experiments, the eyes were perfusion fixed with 
10% formalin buffered solution before further processing for histological evaluation.   
 Eyes were perfused at 2 and 17 mmHg.  Assuming a normal episcleral venous pressure of 
8 mmHg in living eyes,168 these perfusion pressures represent physiological IOP levels of 10 and 
25 mmHg, representing the very low and high ends of the physiological range.169-172   
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6.2.3 SD-OCT Imaging 
An SD-OCT optics engine (Bioptigen, Research Triangle, NC) was coupled with a high 
bandwidth superluminescent diode array (870nm center wavelength, 200nm bandwidth; model 
Q870, Superlum Ltd, Dublin, Ireland). This configuration provided a theoretical axial resolution 
of 1.3µm in tissue.   The optics engine allows the user to specify any number of A-scans per 
frame, and any number of frames, limited only by system memory.  It also allows the user to 
specify any number of sequential A-scans to be acquired in a single location during a raster scan 
for the purpose of averaging and Doppler assessment; also limited only by system memory. Each 
eye was scanned twice at the limbus, first at low perfusion pressure then at elevated perfusion 
pressure.  Each set of images was comprised of 36 individual radial scan sets; three at each 
centered at each clock hour, and offset to the left and right.  The angle of each set of clock hour 
scans was set so that the center clock hour scan was on a radial line from the center of the pupil 
(i.e. the 9 o’clock scan was at 0o, the 10 o’clock scan at 30o, the 11 o’clock scan at 60o, etc.). The 
protocol consisted of 700 x 20 A-scans probing a 2x3mm area of tissue with 2mm slab depth.  
Each A-scan was repeated 18 times, and the average of those 18 scans recorded.   
6.2.4 Image Processing 
No pre-processing was necessary, as 12 sequential A-scans from each transverse location 
were averaged and the averaged data stored at the time of acquisition.  Images were resampled to 
provide a 1:1 pixel aspect ratio in each frame; from 700 x 1024 to 1024 x 1024. The “Set Scale” 
tool was then used to set 1024 pixels to 2mm, allowing spatial measurements directly from the 
image.  Contrast was adjusted to maximize visualization of SC.  SC was traced by hand with the 
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“freehand selection tool” and its area measured (Chapter 3, Figure 10).  The line tool was used to 
measure SC length and height (Figure 15).  Measurements were compared by paired t-test within 
each eye, with a p value of 0.05 or less considered significant. 
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6.3 RESULTS 
The right and left eyes (OD and OS respectively) had outflow rates of 1.76 and 0.16 μl/min at a 
perfusion pressure of 2 mmHg respectively.  At 17 mmHg, right and left eye flow rates were 
3.42 and 0.7 μl/min respectively (Table 6).  
Fifteen paired locations were identified, 4 OD (10 o’clock) and 14 OS (at 4, 8, 9 and 10 
o’clock).  There was no significant change in the length of SC in either eye when measured at 
high and low perfusion pressures.  SC height was statistically significantly reduced in the high 
perfusion pressure compared to the low perfusion pressure in both right and left eyes (p = 0.041 
and 0.0014 respectively; Figures 15, 16).  SC cross-sectional area was statistically significantly 
reduced in the higher perfusion pressure in the left eye (p = 0.0003) and reduced in the right eye 
(p = not significant).  Measurements are provided in Table 6. 
Table 6. Schlemm’s canal height, length, and cross-sectional area at 2 IOP levels 
 
!
Eye$
Perfusion$
Pressure$
(mmHg)$
Outflow$
Rate$
(μl/min)$
Height$
Mean$(SD)$
(μm)$
Length$
Mean$(SD)$
(μm)$
Area$
Mean$(SD)$
$(μm2)$
OS! 2! 0.17! 43.95!(13.95)! 345.82!(67.91)! 17291.82!(5456.87)!
OS! 17! 0.6! 27.96!(9.92)! 344.51!(89.12)! 14070.91!(4348.32)!
OD! 2! 1.76! 21.75!(7.73)! 329.75!(70.01)! 9266.50!(3809.60)!
OD! 17! 3.42! 14.75!(7.54)! 323.00!(94.52)! 5627.25!(891.82)!
!
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6.4 DISCUSSION 
6.4.1 Summary of Findings 
In this study, we found that IOP elevation decreases SC cross-sectional area and height. The 
thickness and cross-sectional area of SC were reduced with no change in SC length.  
Subjectively, IOP elevation was observed to displace the inner wall of SC anteriorly.  These 
changes were readily observable in sequential slices (Figure 18). In the third panel of Figure 18, 
the IOP elevation pushes SC to near collapse. The impact of these morphological changes on 
outflow facility remains unknown. 
6.4.2 Limitations 
Under normal physiological conditions, there is approximately 8mmHg venous pressure.  This 
may provide resistance to the IOP induced movement of the inner wall of SC that is not present 
in the cadaver flow model.  It is possible that these findings may not be applied to living eyes.  
Imaging of SC in living eyes at baseline and increased IOP is ongoing. 
In the present study, a representative location was subjectively identified and used for a 
measurement of SC height.  The amorphous morphology of SC presented difficulties in 
determining a representative value for its thickness.  In future studies, as automated analysis 
techniques are developed, it may be possible and beneficial to measure all SC thicknesses in 
sequential A-scans and use their mean as the representative thickness.  In this study, the primary 
objective in selecting a measurement location was to use visible landmarks in SC to ensure that 
the same location was used at both pressure levels (Figures 15 and 16).  
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6.4.3 Conclusions 
In conclusion, SC inner wall collapses with elevated IOP in human cadaveric eyes.  
These morphometric changes can be observed by SD-OCT.  Volumetric scans are required to 
locate image pairs at single locations.  These findings agree with the findings in the bovine 
perfusion model, and may describe the physiologic consequence of IOP elevation on outflow 
structure morphology. 
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7.0  THREE DIMENSIONAL VISUALIZATION OF AQUEOUS OUTFLOW 
SYSTEM MACROSTRUCTURES 
7.1 INTRODUCTION: WHAT DO THE SMALL MOVING DOTS BETWEEN SD-
OCT FRAMES REALLY REPRESENT? 
Having established the abilities of SD-OCT to measure Doppler shifts, and to image outflow 
structures in cross-section, the next step toward clinical implementation of flow measurements is 
the establishing the morphology of the outflow structures.  In Chapter 3, the connectivity 
between SC and the outflow vasculature in two-dimensional (2D) slices was introduced, but the 
3D morphology of the vasculature distal to Schlemm’s canal has yet to be demonstrated.  In this 
chapter, advanced image processing is used to assemble 3D morphometric virtual castings from 
the 2D image stacks. 
SD-OCT and ultrasound imaging of the anterior segment have produced cross-sectional 
images of the drainage system (Figure 17), but these do not yield sufficient visualization to 
ascertain the condition or density of the complex 3D structures of the aqueous humor outflow 
system.149,173,174 In Figure 17, the anterior chamber angle is scanned by SD-OCT. Scans contain 
portions of the iris, cornea, and limbus (Figure 17A). Within the scan (Figure 17B) Schlemm’s 
canal and aqueous veins, and the intrascleral venous plexus (ISVP) are seen. 
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Figure 17. Scan orientation and structure identification in SD-OCT anterior segment scans 
 SD-OCT rapidly quantifies tissue reflectance in 3D cubes.100,175 Coupling the high 
scanning speed with ultrahigh resolution, it is possible to visualize the individual components of 
the aqueous humor outflow system from the anterior chamber throughout the system of aqueous 
veins in the living human eye. 149  However, shadows from superficial structures may obscure 
the deeper structures.149  Superficial outflow structures, specifically the ISVP and episcleral 
veins, are readily visualized by SD-OCT.   The purpose of the present work was to develop a 
method for visualizing the 3D structures of the conventional aqueous humor outflow system in 
human cadaver eyes during perfusion with SD-OCT.  After imaging, these same eyes were 
processed and examined by light microscopy for correlative histology. 
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7.2 METHODS 
7.2.1 Ethics Considerations 
Human cadaver eyes with no history of eye disease, trauma or ocular surgery other than cataract 
were obtained from the Florida Eye Bank (Miami, FL), and the Center for Organ Recovery and 
Education (Pittsburgh, PA). The Committee for Oversight of Research Involving the Dead of the 
University of Pittsburgh approved the study. Consent for the use of all tissues for research was 
obtained by the individual agency responsible for harvesting and supplying the tissue.   
 
7.2.2 Tissue Preparation and Perfusion 
To prepare for perfusion, seven eyes (Table 7) were wrapped in saline-soaked gauze, submerged 
in normal saline, and warmed to 340C.   
Table 7. Perfusion conditions in cadaveric eyes   
 
Eyes were then placed in front of the SD-OCT scanner in a custom-made fixation mount. 
Throughout the experiment, the eye was irrigated with 400C saline to prevent dehydration and to 
minimize cooling.  A 27-gauge needle was inserted into the peripheral cornea, with the needle tip 
passing through the pupil and positioned posterior to the iris and anterior to the lens.  This 
positioning prevented artificial deepening of the anterior chamber during perfusion and 
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artifactual increases in outflow facility.176  Barany’s mock aqueous humor 165 was used to 
perfuse the eyes. The initial 20 minutes of perfusion was used to establish baseline outflow.  The 
rate of perfusion was determined by recording the weight of the aqueous humor in the reservoir 
in real time, 20 measurements per second.  Measurements were recorded by a 4-channel 10-bit 
digital acquisition system (DATAQ Instruments, Akron, OH).  Immediately after completion of 
the perfusion experiments, the eyes were perfusion fixed with 10% formalin buffered solution 
before further processing for histological evaluation.   
 Perfusion pressure is the hydrostatic force between the anterior chamber pressure and the 
pressure within the vessels receiving aqueous humor outflow.  In this study, a normal episcleral 
venous pressure of 8 mmHg in living eyes was assumed.168  The first two intact eyes were 
perfused with an anterior chamber pressure of 20 mmHg.  Since the episcleral venous pressure in 
a cadaver eye is approximately 0 mmHg, an anterior chamber pressure of 20 mmHg produced a 
perfusion pressure equivalent to an IOP of 28 mmHg in a living eye.  An anterior chamber 
pressure of 10 mmHg yielded a perfusion pressure equivalent to an IOP of 18 mmHg in a living 
eye.  
 We previously established the ability to image the structures of the aqueous humor 
outflow system throughout.149 In the cadaver model, there is no active circulatory system present 
to remove aqueous humor expelled from the outflow system.  We found that fluid gradually 
accumulates in the conjunctiva and Tenon’s capsule when that tissue was left intact on the globe 
(Figure 20), causing shadows obscuring visualization of outflow structures. Figure 20 shows the 
cross-sectional scan of the region of the limbus in a perfused eye reveals that the conjunctiva and 
Tenon’s capsule engorge with mock aqueous humor.  A section of the limbus is seen after being 
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perfused for 5 minutes (Figure 18 left) and 60 minutes (Figure 18 right) showing thickening of 
the superficial tissue layers (black arrows). 
 
Figure 18. Mock aqueous thickens superficial tissue layers 
Therefore, we found that cadaver eyes require the removal of these layers prior to perfusion to 
produce images of equal quality to those obtained in unperturbed living eyes.  The conjunctiva 
and Tenon’s capsule were dissected in all but the first set of eyes. 
 Four eyes were perfused and imaged at 10 mmHg, and then perfusion fixed at 10 mmHg 
for histology.  One of these eyes was first imaged at a perfusion pressure of 0 mmHg.  One eye 
was perfused and imaged at 20 mmHg.  After imaging, it was perfusion fixed at 20 mmHg.  
7.2.3 SD-OCT Imaging 
An SD-OCT optics engine (Bioptigen, Research Triangle, NC) was coupled with a high 
bandwidth superluminescent diode array (870nm center wavelength, 200nm bandwidth; model 
Q870, Superlum Ltd, Dublin, Ireland). This configuration provided a theoretical axial resolution 
of 1.3µm in tissue.   The optics engine allows the user to specify any number of A-scans per 
frame, and any number of frames, limited only by system memory.  It also allows the user to 
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specify any number of sequential a-scans to be acquired in a single location during a raster scan 
for the purpose of averaging and Doppler assessment; also limited only by system memory.  Two 
scan protocols were created; one optimized for the acquisition of 3D data (the “volume” 
protocol) and one optimized for visualization of individual frames (the “2D slice” protocol).  
Each eye was scanned twice at the limbus, first with a protocol optimized for 3D volumes, and 
the second with a protocol optimized for visualization of 2D slices.  Each set of images was 
comprised of 36 individual radial scan sets; each clock hour imaged at its center, and offset to the 
left and right.  The angle of each set of clock hour scans was set so that the center clock hour 
scan was on a radial line from the center of the pupil (i.e. the 9 o’clock scan was at 00, the 10 
o’clock scan at 300, the 11 o’clock scan at 600, etc.).  The 3D volume scan protocol was limited 
by system memory, and consisted of 512x512 A-scans probing a 2x3 mm area of tissue (Figure 
19 C and D).  This scan protocol only moved the 20µm diameter SD-OCT beam 9µm between 
A-scans, thus including a single tissue volume in multiple adjacent samples (oversampling).  
Acquiring oversampled SD-OCT data allowed post-process averaging.  The 2D slice protocol 
consisted of 700 x 20 A-scans probing a 2x3mm area of tissue.  Each A-scan of the 2D slice 
imaging protocol was repeated 18 times, and the average of those 18 scans recorded (Figure 19 
A and B).  This method was previously described in detail.177   Spectral domain optical 
coherence tomography images would normally be displayed with a low level of brightness 
(Figure 19A). In the case of highly averaged image data (700 A-scans in this frame; each A-scan 
the average of 18 sequentially acquired A-scans), brightness can be increased (Figure 19B) 
allowing visualization of deep low signal structures such as the iris, angle, trabecular meshwork, 
and endothelial /Descemet’s complex without compromising due to visible noise.  SD-OCT 
images obtained without averaging (512 A-scans, each presented without averaging) and 
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displayed with a low level of brightness (Figure 19C) have an appearance similar to those 
obtained with averaging at the same noise suppression level.  But, increasing brightness reveals 
the noise masking the deep layers where the signal is low (Figure 19D). 
 
Figure 19. Contrast adjustment to improve visualization of outflow structures 
7.2.4 Correlative Light Microscopy Imaging 
After imaging using SD-OCT, two eyes were perfusion-fixed at 10 mmHg and one eye was 
perfusion fixed at 20mmHg.  Following perfusion fixation, the three eyes were placed in 10% 
formalin buffered solution overnight and then transferred to PBS.  The anterior chamber of each 
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eye was cut radially into 12 pieces (1 clock hour each) and processed for light microscopic 
examination. The sections were post-fixed with 2% osmium tetroxide (Electron Microscopy 
Sciences, Hatfield, PA) in 1.5% potassium ferrocyanide (Fisher Scientific, NJ) for 2 hours, 
dehydrated in a graded series of ethanols, and embedded in Epon-Araldite (Electron Microscopy 
Sciences, Hatfield, PA). 3 µm sections were cut (4 blocks each eye at 3, 6, 9 and 12 o’clock) and 
stained with 1% Toluidine Blue (Fisher Scientific, NJ). Light micrographs were taken at an 
original magnification of 4X and 10X.  The histological images were compared with SDOCT 
images from the same locations. 
7.2.5 SD-OCT Image Processing 
Raw SD-OCT scan data are analyzed by histogram.  The 75% of SD-OCT data with the 
lowest reflectance values are set to 0 when displayed.178 This approach is effective for the 
subjective improvement of visualization of highly reflective structures, but if the structures are in 
a region of low signal strength, they will not be displayed.  In the slice image set, averaging 
during image acquisition improved visualization of structures with low reflectance.  Increasing 
image brightness in highly averaged image data further improves visualization of the deep 
outflow structures (Figure 19).  However, in the volume image data set, raw data acquired from 
deep outflow structures were difficult to visualize.  Increasing image brightness increases 
visualization of deep low-reflectance structures, but also increases the appearance of speckle 
noise, obscuring structure details (Figure 19).  This can be overcome by post-processing 
averaging.  The volume image protocol spatially oversamples the tissue, allowing averaging with 
minimal loss of structural information.  A floating 5x5 pixel transverse kernel, consisting of 5 
pixels in each of 5 adjacent frames, was used to produce an average dataset, using customized 
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software of our own design (Appendix A, Figure 20).  Visualization of deep layers within the 
post-processing averaged volume dataset was comparable to that of the slice data (Figures 20 and 
19B). 
 
Figure 20, Averaging the 3D volume increases visualization 
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Figure 21. Image processing steps to isolate the ISVP 
 Further image processing was performed using ImageJ 64 (ImageJ 1.40g, 
http://rsb.info.nih.gov/ij/).  Images were resampled to provide a 1:1:1 voxel aspect ratio in three 
dimensions; from 512 x 512 x 1024 (Figure 21A) to 342 x 512 x 342 (Figure 21B) for each 
2x3x2mm volume.  Images were then inverted so that the black collector channels appeared as 
white structures (Figure 21C).  The ImageJ “subtract background” filter was applied with a 30 
pixel kernel and without further averaging (Figure 21D).  Contrast was then adjusted to isolate 
the collector channels (Figure 21E), and the volumes rendered using the ImageJ 64 3D viewer 
plug-in (Figure 22).  The isolated intrascleral venous plexus image data was rendered in 3D to 
visualize the ISVP during active outflow.  Figure 22 shows one of 36 circumferential scans of 
the limbus, featuring a portion of the venous network. The red marker on the right indicates the 
X, Y, and Z axes of the 3D space, with the interrogating SD-OCT beam projecting down the Z-
axis, and raster scanning the X-Y plane.  
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Individual stacks were opened in Amira 4.1 (Visage Imaging Inc., San Diego, CA) and rendered 
in 3D space with the Voltex module (2D texture, rendering down sample 3,3,3).  Stacks were 
manually assembled in 3D space by overlaying aqueous veins and structures visible in adjacent 
scans.  The volume scan protocol provided a large degree of overlap; most individual aqueous 
veins were contained in two images, and occasionally in three. 
7.3 RESULTS 
7.3.1 Subjective Observations 
Outflow structures from the TM through the CC could be visualized throughout the limbus.  The 
slice imaging protocol provided better visualization of outflow structures in cross-section, likely 
due to the combined effects of spatial oversampling (700 A-scans per frame) and aggressive 
averaging (18 sequentially acquired A-scans averaged to produce each displayed A-scan; Figure 
19B).  Unfortunately, scanner memory restrictions limit the number of frames that can be 
acquired using this protocol.  The low number of frames makes the slice protocol unsuitable for 
enface imaging or 3D reconstructions.  The volume imaging protocol provides excellent enface 
images, and post-processing averaging allows the recovery of detail within deep structures 
(Figure 20).  The sampling density of the volume protocol also allows high-resolution 3D 
reconstruction of the outflow system within individual scans (Figure 22).   
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7.3.2 Effect of Pressure 
It has been shown that exposure to elevated IOP may lead to closure of SC as the TM pushes and 
compresses the inner wall towards the outer wall.166 At 20 mmHg perfusion pressure, SD-OCT 
revealed very few locations with a visible patent SC.  This finding was confirmed by histology.  
Figure 23 shows a histological section from the 6:00 position in an eye perfused at 20 mmHg, 
which presents with an open ostium (Figure 23A-1) despite the anterior surface of the trabecular 
meshwork compressing SC (Figure 23A-2).  Vessels of the ISVP are visible (Figure 23A-3). The 
same eye at the 9:00 position also presents with a compressed SC, but no visible ISVP 
vasculature (Figure 23B).  A different eye perfused at only 10 mmHg presents with a large open 
SC at the 9:00 position (Figure 23C-4).  At the 12:00 position, SC ISVP vessels are present 
(Figure 23D-5), as are SC and open ostia (Figure 23D-6). 
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Figure 23. Effects of pressure on SC morphology 
Collector channel ostia and patent aqueous venous structures were observed by SDOCT and 
confirmed by histology (Figure 23).  At 10 mmHg, SC was not compressed (Figure 23).  Smaller 
scleral veins running from the ISVP down toward the deep scleral venous plexus were frequently 
observed in individual frames of the 3D datasets, but seldom achieved sufficient contrast, 
relative to background tissue, to be observed in the 3D reconstructions.  Occasionally, a large 
aqueous vein could be observed, but only when isolated from other branches of the ISVP.  Figure 
24A shows the front and side views of a scan obtained from one eye.  Note the vessels that 
penetrate perpendicular to the ISVP. A histological section from the 6:00 position in an eye 
perfused at 20 mmHg can be rotated (Figure 24B) to expose the posterior surface (Figure 24C) 
revealing two aqueous veins. (white arrows) 
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7.3.3 Composite 3D Casting of the Outflow System 
 After individually processing the 36 scans of the limbus of the structural imaging 
protocol a composite casting of the collector channels of the aqueous humor outflow system was 
rendered (Figure 27).  The densest arrays of aqueous veins within the ISVP were observed near 
the 6 and 12 o’clock positions.  In Figure 27, 36 circumferential limbal scans were processed and 
assembled manually in 3D space to yield a full casting of the episcleral and intrascleral venous 
plexus throughout the limbus in-situ during active perfusion. 
 
Figure 25. Circumferential virtual casting of the outflow system 
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7.4 DISCUSSION 
7.4.1 Summary of Findings 
We present the first virtual casting of superficial venous plexus of aqueous humor outflow 
system.  The imaging process is completely non-contact and requiring no dyes or contrast agents.  
In living human eyes, the imaging process is completely non-invasive.  In the cadaver model, the 
conjunctiva and Tenon’s capsule must be removed to produce images of similar quality as those 
produced in living eyes.  Virtual casting was made possible by the high degree of contrast 
between the superficial venous plexus of aqueous humor outflow system (including aqueous 
veins) and surrounding tissues achieved by aggressive post-processing averaging.   
 There was good agreement between features observed in the SD-OCT 2D scans and the 
corresponding histological sections (Figure 23).  This included the appearance of SC under 
different perfusion pressure conditions as well as the presence or absence of the open superficial 
vessels comprising the ISVP.   
7.4.2 Differences between In-Vitro and In-Vivo Conditions 
 A cadaver eye, as used in this experiment, differs from a living eye.  Specifically, the 
cadaver eye lacks circulatory-related pulsations in IOP and blinking which each may contribute 
force to outflow.179  The change from a pulsatile to non-pulsatile environment may alter the 
conditions dictating the preferential location of outflow within the eye.  There is also a lack of 
pulsatility in the vessels receiving aqueous humor.   In the living eye, scleral veins receive 
aqueous humor in an environment of transient pressure waves.   In the cadaver eye, aqueous 
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humor arrived in vessels with no backpressure.  During perfusion, the vessels were observed to 
fill with aqueous humor, resulting in some small constant backpressure.  Combined with gravity, 
it is possible that the preferential outflow path in a cadaver model differs significantly from that 
of a living eye.  But, if gravity were the only influence, we would have expected full aqueous 
vessels in the inferior with a gradual diminution of the casting until it appeared empty in the 
superior. The present study found the fullest ISVP castings in the superior and inferior quadrants. 
Previously, we reported that in living human eyes, SC near CC ostia appeared to be larger in the 
nasal quadrant of the limbus, thought only the lateral quadrants were measured in that study.149  
Our initial data indicated that the conjunctiva and Tenon’s capsule needed to be removed 
before perfusion in order to image the deep layers of the limbus with quality equal to that 
obtained in living human eyes and avoid distention of the outer tissue layers as they filled with 
aqueous humor.  It is likely that the superficial-most vessels of the outflow system were also 
removed.  In the remaining tissues, it is impossible to determine what percentage, if any, of the 
virtual casting consisted of ISVP or the midlimbal intrascleral plexus, or some combination 
therein.  Interconnectivity was observed within the vascular network. The lack of blood flow 
supports the contention that the casting is of active aqueous humor outflow, though the identity 
of the actual observed vessels, whether aqueous vessels or venules, can only be inferred by their 
location and connectivity.  We are confident that some portion of the castings consisted of 
aqueous veins, as those portions were observed to penetrate into the limbus (Figure 26) and 
could be seen in individual frames extending directly to SC ostia.  Nevertheless, since there was 
no active cardiac circulation in the imaged tissues, all passages captured in the casting were open 
and connected because they were carrying mock aqueous humor as part of the outflow process.  
 88 
It would be desirable to have a complete casting of the outflow system, down to SC.   A 
recent study produced virtual castings of the outflow system at the level of SC in sections of a 
stained eye using micro CT.180  In the present method, only the superficial venous plexus or 
occasional large penetrating aqueous veins could be optically isolated from surrounding tissues, 
though this was accomplished non-invasively and without introduction of any contrast agents.  It 
is possible that a more sophisticated image processing technique could include more structures in 
the casting.  Specifically, imposing a connectivity requirement for inclusion in the casting might 
reduce the use of contrast for isolation and allow the smaller structures to be included despite 
weak signal levels.    
As we continue to develop the ability to image aqueous humor outflow as it occurs, our 
goals is to be able to detect deficits associated with disease, and determine the effects of 
glaucoma medications and surgical interventions on outflow and the associated structures.   
Currently the two largest impediments to clinical implementation are penetration and eye 
movements.  The structural and functional scan protocols used in this study required 
approximately 10 seconds each, with a data acquisition rate of 28,000 A-scans per second.  This 
is far too slow to obtain useful data in human eyes, as eye movement artifacts are readily visible 
in the typical ~2 second scans obtained with commercially available SD-OCT’s.  However, 
“cutting edge” SD-OCT systems have achieved a scan rate of 1.37 million A-scans per second, 
which would reduce the scan time to 0.1 seconds.175 Longer wavelength systems may overcome 
current limitations in penetration, but despite the limits of the 870nm centered system, using 
aggressive averaging we are able to resolve the structures of the angle and conventional outflow 
system (Figures 19 and 20).    
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 Clinical and research use will require the development of meaningful parameters that 
quantify outflow structures.  The outflow structures are too numerous and dense, and with 
marked regional variation, to arbitrarily choose individual CC’s to represent outflow.  
Assessment of the outflow venous network will involve an automated quantification of aqueous 
vein density and the distribution of vein sizes.  Quantification of the number of branch points 
may also have some clinical meaning.  Ultimate utility will depend on determination of how each 
of these potential parameters is affected by the presence of glaucoma.   
7.4.3 Conclusions 
 In conclusion, we present the first virtual casting of aqueous humor outflow structures 
obtained non-invasively in-situ ex-vivo.  Continued development of this technique may lead to 
clinically useful direct assessment of outflow in patients with glaucoma. 
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8.0  REPRODUCIBILITY OF 3D VIRTUAL CASTING OF THE AQUEOUS HUMOR 
OUTFLOW SYSTEM IN THE LIVING HUMAN EYE 
8.1 INTRODUCTION 
In chapter 7, the ability to create virtual castings of the outflow system was demonstrated in 
cadaveric eyes.  This suggests that enhanced processing of structure images may be useful in the 
living human eye for the mapping and study of outflow structures, and the possible measurement 
of Doppler signals within.  But, the utility of these measurements requires that they identify and 
display structures in a consistent and reproducible manner.   
There is a SD-OCT scanner in clinical use equipped for anterior segment scanning, 
including an FDA approved protocol for volumetric scans of the limbus.  Transition of this 
technology to clinical use will be accelerated if it can be accomplished with existing clinical 
equipment.  The purpose of the present study was to determine if the same structures can be cast 
in sequential volumetric scans of the human limbus with a clinically used SD-OCT platform.   
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8.2 METHODS 
8.2.1 Ethical Considerations 
The study was conducted in accordance with the tenets of the Declaration of Helsinki and the 
Health Insurance Portability and Accountability Act. The institutional review board of the 
University of Pittsburgh approved the study. All subjects before participation gave written 
informed consent. 
8.2.2 Study Design 
Ten healthy volunteers were recruited from the staff and faculty of the UPMC Eye 
Center. SD-OCT images of the limbus were obtained from the nasal quadrant of the right eye in 
three sequential scans at a single visit. In the previous chapter, unobstructed visualization of 
outflow vessels was limited in the lateral quadrants, however constraints of the scanner limit 
scans to the nasal and temporal quadrants.  It was likely that vessel isolation would not be 
possible in all subjects.  Images were 4x4mm, with a slab thickness of 2mm.  Two independent 
observers created 3D virtual casts of visible outflow structures.  Structural features were 
subjectively compared, specifically to determine if the same features could be identified in 
multiple scans of the same region. 
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8.2.3 Imaging of SC  
SD-OCT (Cirrus HD-OCT; Carl Zeiss Meditec, Inc., Dublin, CA) was used image SC.  512 x 
1024 x 128 samples were acquired in a 4 x 2 x 4 mm volume of the limbus. The acquisition rate 
was 27,000 A-scans per second. Moving chin and forehead rests were used to center the eye in 
the image frame, and then verbal commands were used to position the desired region of the 
limbus in the image. Scan time was 2 seconds.   
8.2.4 Image Processing and SC Visualization 
Images were pre-processed with a 3x3x3 kernel-size averaging filter using software of our own 
design (Appendix A). Pre-processed images filtered with an automatic processing routine in 
which images were blurred and contrast enhanced using by local contrast enhancement by 
adaptive histogram filtering, and then background was subtracted; all in Fiji (ImageJ 1.45q, NIH, 
http:imagej.nih.gov/ij).  A final manual adjustment of contrast and brightness was made to 
isolate outflow structures and minimize noise.  
8.2.5 Statistics 
The image data created in this study did not produce numerical data.  3D casts were subjectively 
examined to determine if the same structures could be identified in all casts. The frequency of 
success is reported. 
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8.3 RESULTS 
Two observers produced the virtual outflow vascular casts in the 10 Figures below.  The top 
rows are all casts from the first observer, and the bottom row those of the second observer.  Each 
row features three casts from each of the three sequential scan volumes obtained. The differences 
observed in texture result from personal differences in the observer’s technique regarding the 
best way to manually adjust the contrast in the final step. Figure 28 demonstrates the various 
levels of vessel visibility achieved with varying levels of noise reduction via contrast 
enhancement.  While the upper left panel of Figure 28 most cleanly isolated the observable 
vasculature, the lower center panel presents a casting containing a wider range of gray scale, 
producing a more textured casting with more complete vasculature network.  In all Figures 
except 30 and 32, arrows mark identifiable vascular structures that are both consistently visible 
throughout the three castings of the subject, and found by two independent observers.  As 
discussed in the previous chapter and methods, the nasal and temporal quadrants tend to present 
with more noise and obscured visualization of the vessels.  In this cohort, two of the subjects, 
shown in Figures 30 and 32, failed to present with prominent vasculature. 
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8.4 DISCUSSION 
Sequential scans of the limbus consistently produced reproducible visualization of vascular 
structures with identifiable morphologies in 8 of 10 subjects.  In the two subjects in whom no 
clear vessels were seen, the consistent presence of noise, as opposed to the appearance and 
disappearance of vessels, is equally supportive of the reproducibility of the technique.  This 
consistency of vascular appearance or absence was present between two independent observers.  
In the series of castings, textural differences were present as the result of each observer’s 
technique in the manual adjustment of contrast.  The completeness of the vascular network 
varied with the level of contrast enhancement, and was greater in “softer” images, or those in 
which a larger range of gray values was present.  When the contrast enhancement pushed the 
images toward binary, the remaining noise was more prominent and effectively masked 
otherwise viewable vascular networks.  In order to reduce this noise effect; larger portions of the 
signal content were reduced along with the noise resulting in the loss of visualized vessels (See 
Figure 28 upper left versus Figure 28 lower center).   
Recall from the previous chapter that, in the cadaveric eyes, the nasal and temporal 
quadrants presented with the least distinct castings of outflow vasculature.   In the present study, 
the findings in living eyes are consistent with those of the cadaveric eyes; specifically, there were 
only a small number of vessels that could be identified by casting.  It is possible that these 
regions contain a similar vascular content, but also contain more sources of noise that obscure 
present vessels.  Ultimately, concordance with actual physiological content will required a 
comparison with true physical castings of these vessels for side-by-side comparison with the 
virtual casts.  This will be impossible in living human eyes, and an animal model may ultimately 
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be necessary for comparison of castings of living eyes versus actual physical castings of the 
outflow system. 
 In conclusion, the vascular casting technique presented in the previous chapter in 
cadaveric eyes can be performed with data obtained from living eyes using off-the-shelf clinical 
scanners. These castings are reproducible, showing either vascular structure consistently from 
multiple scans of a single area, or the lack thereof with equal consistence.  Independent observers 
analyzing the same set of scans produce virtual castings displaying vascular networks with the 
same morphology (or noise) depending on the scan content.  
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9.0  THREE DIMENSIONAL VISUALIZATION OF AQUEOUS OUTFLOW 
SYSTEM MACROSTRUCTURES: SCHLEMM’S CANAL AND COLLECTOR 
CHANNELS 
9.1 INTRODUCTION: 2D IS COOL, BUT CAN YOU SEE SCHLEMM’S CANAL IN 
3D? 
We previously demonstrated the ability to visualize SC non-invasively in living human eyes in 
two dimensions (2D), and more distal structures in a cadaver eye outflow model in three 
dimensions (3D).149,181 Those images were acquired with a SD-OCT device in an experimental 
configuration.  The purpose of this study was to demonstrate 3D visualization of the aqueous 
outflow system in living human eyes using commercially available SD-OCT systems. 
9.2 METHODS 
9.2.1 Ethics Considerations 
The study was conducted in accordance to the tenets of the declaration of Helsinki and the 
Health Insurance Portability and Accountability Act.  The institutional review board of the 
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University of Pittsburgh approved the study.  All subjects gave written informed consent prior to 
participation in the study.  
9.2.2 Imaging of Schlemm’s Canal in Human Eyes 
Six healthy volunteers were recruited from the staff and faculty of the University of Pittsburgh 
Medical Center (UPMC) Eye Center.  SC and aqueous veins were imaged using two 
commercially available SD-OCT devices: Cirrus HD-OCT (Carl Zeiss Meditec, Dublin, CA) and 
a modified Bioptigen SDOIS (Bioptigen, Research Triangle, NC). The Cirrus light source has a 
50nm bandwidth centered at 840nm, resulting in a 5µm coherence length in tissue.  The 
Bioptigen optics engine was coupled with a quad diode light source with an 870nm center 
wavelength and a 200nm bandwidth (Q870, Superlum Ltd., Dublin, Ireland). The light source 
had a coherence length of 1.3µm in tissue.   
Two scan protocols were used; one optimized for the acquisition of 3D data (the 
“volume” protocol, 512x512 A-scans with no averaging, ~9.4 second acquisition time) and one 
optimized for visualization of individual frames (the “2D slice” protocol, 700x40 A-scans, each 
averaged 8 times at acquisition, ~8 second acquisition time). Each protocol imaged a 4x4 mm 
transverse area of the limbus with a 2mm A-scan length at the 3, 6, and 12 o’clock positions.  
Sequential scans in the volume protocol had a center-to-center spacing of 7.8µm.  With a lateral 
resolution of 20µm, there was a high level of overlap (resampling) of tissue with any single point 
within the scan volume being sampled by 5 axial scans (center plus nearest neighbors in the x-y 
plane).  Sequential scans in the 2D slice protocol were separated by 100µm.  All scans were 
oriented so that the scan cube was tangential to limbus and the center scan was radial to the 
limbus. 
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The commercially available Cirrus HD-OCT had two FDA approved anterior segment 
scan protocols.  The 512 x 128 A-scan “cube” protocol (~2.5 second scan time) was used, 
covering a 4x4 mm area of the limbus at 3, 6, and 12 o’clock.  Unlike the Bioptigen, which was 
capable of orienting the B-scans at any arbitrary angle, only the 3 and 6 o’clock Cirrus B-scans 
had a radial orientation relative to the limbus while the 12 o’clock scan had a tangential 
orientation.  Sequential frames in the Cirrus scans had a 31µm center-to-center separation.  Raw 
OCT signal data were exported from both devices.   
9.2.3 Image Processing 
Scans were pre-processed with a custom-written OCT browser of our own design (Appendix 
A),182-184 and then visualized in 3D using ImageJ Fiji (ImageJ 1.45k java, 
http://rsb.info.nih.gov/ij/).  Cirrus scans were pre-processed with a 3x3x3-averaging kernel.  
Specifically, each voxel in the dataset was replaced by the average of 27 voxels in surrounding 
3x3x3 3D space. Bioptigen volume images were pre-processed with a flat 5x5 averaging kernel. 
Each voxel was replaced with the average of the surrounding 5x5 voxel 2D plane.  Averaging 
protocols were selected subjectively based on the appearance of the outcome. Processing time for 
averaging was approximately 1 minute per image for both Bioptigen and Cirrus.   
The Fiji “enhance local contrast” filter was used to improve visualization of structure 
throughout.  To create virtual castings, images were inverted so that the black collector channels 
appeared as white structures.  The “subtract background” filter was applied with a 30-pixel 
kernel.  Images were resampled to provide a 1:1:1 voxel aspect ratio in 3D.  Contrast was 
adjusted to isolate the collector channels, and the volumes rendered using the 3D viewer plug-in.  
The total time to produce a 3D visualization was approximately 20 minutes, though multiple 
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attempts to maximize visualization of structures were frequent.  Varying levels of noise sources 
surrounding structures of interest necessitated flexibility in degree to which noise was suppressed 
in order to minimize noise content with minimal loss of image content. 
Two distinct layers of aqueous venous plexuses were subjectively identified in the 2D 
visualizations (Figure 38, white block arrows).  The Cirrus image of the limbus (Figure 36 left) 
clearly reveals Schlemm’s canal (yellow arrows), as well as a distinctive “fallen Y” aqueous 
vein.  The characteristics of this structure can be used to locate the same cross-sectional image 
within the Bioptigen image data (Figure 36 right). Two distinct layers of aqueous venous 
plexuses are visible (white block arrows right), at two depths within the limbus (white block 
arrows, left).  Unlike blood vessels (Figure 38 stars), which cast vertical shadows into the scan 
(X’s), aqueous veins do not create shadowing artifacts in the image. 
 
Figure 36. Cirrus and Bioptigen images of the same tissue location. 
The distance from the surface of the limbus to each aqueous venous plexus was measured 
in the 2D slices in nasal, inferior, temporal, and superior quadrants.  The diameters of aqueous 
veins in each layer of aqueous venous plexus were measured in each quadrant. No fewer than 6 
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of the 40 frames of the “2D” scan protocol were included for each location when venous plexus 
depth and aqueous vein diameter were assessed.    
9.3 RESULTS 
9.3.1 Subjective Observations 
Four males and 2 females (average age 38.5 and 29 years respectively) were imaged on two 
different days.  Outflow pathways were readily visible in both Cirrus and Bioptigen images from 
all eyes (Figure 37).  2D slices reveal both outflow and vascular structures.  Blood vessels cast 
vertical shadows in OCT images185 (Figure 36, x’s).  Shadows can be used to identify blood 
vessels (Figure 36, stars).  Tracing their pathway to Schlemm’s canal can identify aqueous veins, 
and their identity as aqueous veins is confirmed by the lack of shadows (Figure 36, block 
arrows).  The average depth of the superficial and deep aqueous venous plexuses and the average 
aqueous vein diameters are presented in Table 8.  The distance between the surface of the limbus 
and each of the two layers of aqueous venous plexuses was measured in each quadrant.  The 
diameter of aqueous veins within those plexuses was also measured (Table 8). 
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Table 8.  Aqueous venous plexus characteristics 
 
Acquisition of 3D volumetric samples enabled identification of the same location within 
the limbus in both scan sets, based on subjective observation of outflow pathway morphology 
(Figure 36).  Speckle noise obscured visualization of SC and aqueous veins within the raw Cirrus 
scans, but 3x3x3 averaging reduced speckle and allowed clear visualization.  Figure 38 shows a 
contrast-enhanced image sequence obtained with the Bioptigen in which the pathway (underlined 
in orange) from SC (underlined in yellow) is traced to the midlimbal intrascleral plexus.  These 
images are from a sequence of 40 axial slices of the limbus acquired in 8 seconds.  The center-to-
center spacing of the slices in image 33 is 100µm. 
 
Figure 37.  Cirrus before and after averaging 
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Utilizing adjacent frames, the pathway from SC to the mid-limbal intrascleral plexus could be 
traced (Figure 38). 
 
Figure 38. 2D visualization of the outflow pathway from SC to the ISVP 
Virtual casting of the aqueous humor outflow structures between SC and the episcleral 
vasculature, as well as surrounding blood vessels, whose identity is suggested by their relatively 
large size, was feasible with the data produced on each system.  Inclusion of more noise (Figure 
39 right, Bioptigen) allows a more complete virtual casting of the aqueous humor outflow 
pathway (yellow arrows), compared to a casting with heavily suppressed noise (Figure 39 left, 
Cirrus), which washes out many of the outflow structures (yellow arrows) leaving, for the most 
part, large blood vessels (red arrows).  
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Figure 39. Cirrus and Bioptigen castings of the living human ISVP 
The degree to which noise was suppressed altered image content.  Leaving more noise 
(Figure 39 Bioptigen casting right) allowed visualization of aqueous outflow microvasculature 
with a “fishnet” appearance.  Removal of more noise (Figure 39 Cirrus casting left) eliminated 
visualization of the aqueous humor microvasculature, leaving only large blood vessels in the 
casting. 
Figure 40 presents the first virtual castings of SC (asterisks) in the living human eye.  
Several collector channels (arrows) and aqueous veins extending from SC were observed within 
the 4mm section of SC.   
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Figure 40. The living human Schlemm’s canal in-situ 
When the 2D image stack that produced these castings was reviewed, the presence of 4 
aqueous vein branch points were not evident.  SC could be cast from all Cirrus scans at both 
nasal and temporal quadrants (Figure 41, SC marked by asterisks).  When the castings were 
rotated in 3D space, collector channels emanating from SC could be observed in 9 of the 12 
castings.   
 115 
 
Figure 41. Schlemm’s canal castings from all nasal and temporal Cirrus scans 
9.4 DISCUSSION 
9.4.1 Summary of Findings 
In the present study we demonstrate the ability of SD-OCT to acquire volumetric scans of the 
limbus, from which the outflow pathway can be tracked from SC to the superficial vascular 
plexuses in 2D image sequences, and from which virtual castings of those same outflow 
structures can be produced.  We also found that averaging the raw scan data improved 
visualization of the outflow pathway. We present the first 3D castings of outflow structures in 
the living human eye.   
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9.4.2 2D Versus 3D Analysis of Ostia 
The ability to visualize SC and surrounding aqueous veins in 3D increases the ability to detect 
detailed information of the outflow pathway, such as the branch points, in comparison with the 
2D images.    We have previously described a number of instances in which 3D visualization of a 
structure within a raster scan set reveals its identity.186  In the present study, the observation of 
small vessels adjacent to and emanating from SC allowed their identification as collector 
channels despite their weak and hidden appearance when observed in 2D.   
9.4.3 Importance of 3D Imaging of Ostia in Glaucoma 
The ability to cast SC in 3D could improve the management and treatment of glaucoma.  
Visualization of SC and collector channels could give guidance to the glaucoma surgeon wishing 
to improve aqueous outflow through the conventional pathways.  The TM and inner wall of SC 
could be removed specifically in the region of collector channels and their ostia as well as 
aqueous veins to maximize the impact of that surgery on outflow facility and reduction of 
intraocular pressure.  The same is true for devices that would reside in SC and bypass the TM 
and inner wall of SC – placement at the sites in proximity of collector channel ostia would 
potentially maximize their effectiveness in IOP reduction, since aqueous would not have to 
traverse long distances in SC prior to exiting through the collector channels.  Conversely, it is 
possible that leaving currently active regions of aqueous humor outflow undisturbed and using 
implanted devices to enhance outflow by positioning them in regions devoid of observable 
aqueous vein/SC branch points would maximize outflow.  This casting technique may be useful 
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in elucidating the optimal implant placement strategy.  This hypothesis could be tested in the 
perfused cadaver eye model. 
The findings in the present study also include the first virtual castings of the distal 
outflow vasculature in a living eye, similar to the castings of cadaver eyes published in a 
previous study.181  Unlike the previous study, the casting in the living eye includes patent blood 
vessels (Figure 36).  It is likely that, based on their relative size, the large vessels more 
prominent in the Cirrus casting in Figure 39 are blood vessels.  The small aqueous humor vessels 
visible in the Bioptigen casting in Figure 39 features a distinct network of straight segments 
sharing branch points.  Some evidence of this same microvasculature exists in the Cirrus casting, 
but the extent to which it pervades the morphology of the aqueous humor outflow vasculature 
cannot be appreciated.  Unfortunately, visualization of the smaller vessels cannot be 
accomplished without the inclusion of substantial image noise.  A study focusing on the 
morphology of small aqueous vessels is currently underway. 
9.4.4 Conclusions 
3D virtual casting of the aqueous outflow vasculature is possible in living human eyes with 
existing off the shelf general purpose SD-OCT technology. The outflow pathways from SC to 
the superficial vasculature can be identified and tracked, and SC can be cast in 3D from these 
scans.  Post-processing is required to maximize the visualization of the content within.   
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10.0  THREE DIMENSIONAL VISUALIZATION OF AQUEOUS OUTFLOW 
SYSTEM MACROSTRUCTURES: AQUEOUS VENOUS PLEXUSES 
10.1 INTRODUCTION: THERE WERE SMALL HINTS OF VASCULAR 
MESHWORKS IN THE PREVIOUS CHAPTER.  WHAT DO THEY REALLY LOOK 
LIKE? 
The earliest imaging studies intended to elucidate the normal structure of limbal outflow 
vasculature utilized biomicroscopic examination in-situ or in whole enucleated eyes with or 
without the use of contrast.187,188 These early studies established that aqueous humor flowed from 
the anterior chamber (AC) to SC and reached the superficial limbal vasculature via connecting 
vessels. Further studies have shown the majority of aqueous humor leaves the eye through limbal 
structures that comprise the conventional pathway (TM, Schlemm’s canal, collector channels, 
aqueous venous plexus and episcleral veins). The aqueous venous plexus is a complex network 
that includes the deep, midlimbal and perilimbal scleral plexuses leading to scleral veins or 
Ascher’s aqueous veins which bypass this tortuous pathway and connect directly from SC to the 
episcleral veins.26,27,29,189,190  
SD-OCT and ultrasound imaging of the anterior segment have produced cross-sectional 
images of the drainage system, but these do not yield sufficient visualization to ascertain the 
condition or density of the complex 3D structures of the aqueous humor outflow system.149,173,174 
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SD-OCT rapidly quantifies tissue reflectance in 3D cubes at speeds up to 1.37 million axial scans 
(A-scans) per second.95,100,191 Coupling the high scanning speed with ultrahigh resolution, it is 
possible to visualize the individual components of the aqueous humor outflow system from the 
anterior chamber throughout the system of aqueous veins in the living human eye.149 In an earlier 
study visualizing the gross morphology of the aqueous humor outflow channels, a not previously 
described fine meshwork structure was observed in the aqueous humor capillary networks.150 
The purpose of the present study was to create 3D visualizations of the aqueous humor outflow 
vasculature to reveal morphometric details of microvasculature visible with an improved SD-
OCT processing schema and to compare microvascular morphologies to those found in corrosion 
casting studies.  
10.2 METHODS 
10.2.1 Ethics Considerations 
Human cadaver eyes with no history of eye disease, trauma or ocular surgery other than cataract 
were obtained from the Florida Eye Bank (Miami, FL) and the Center for Organ Recovery and 
Education (Pittsburgh, PA). The Committee for Oversight of Research Involving the Dead of the 
University of Pittsburgh approved the study. Consent for the use of all tissues for research was 
obtained by the individual agency responsible for harvesting and supplying the tissue. In 
addition, in-vivo healthy eyes were imaged recruited from the staff of the University of 
Pittsburgh. The living subject portion of the study was conducted in accordance with the tenets 
of the declaration of Helsinki and the Health Insurance Portability and Accountability Act. The 
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institutional review board of the University of Pittsburgh approved the study. All subjects gave 
written informed consent prior to participation in the study.  
10.2.2 Tissue Preparation and Perfusion 
Seven cadavers and three living eyes were imaged (Table 9). Perfusion pressures are 
provided in the Table.  The time window between death and fixation was less than 24 hours. To 
prepare for perfusion, ex-vivo eyes were wrapped in saline-soaked gauze, submerged in normal 
saline and warmed to 34°C. Eyes were then placed in front of the SD-OCT scanner in a custom-
made fixation mount. Throughout the experiment, the eye was irrigated with 40°C saline to 
prevent dehydration and to minimize cooling. 
Table 9. Perfusion Pressures 
 
A 27-gauge needle was inserted into the peripheral cornea, with the needle tip passing 
through the pupil and positioned posterior to the iris and anterior to the lens. This positioning 
prevented artificial deepening of the anterior chamber during perfusion and artificial increases in 
outflow facility.176 Barany’s mock aqueous humor was used to perfuse the eyes.165 The initial 20 
min of perfusion was used to establish baseline outflow. The rate of perfusion was determined by 
recording the weight of the aqueous humor in the reservoir in real time at 20 measurements per 
second. Measurements were recorded by a 4-channel 10-bit digital acquisition system (DATAQ 
!
Eye  Condition  Anterior Chamber 
Pressure  
1, 2  Intact  20 mmHg  
3  Conjunctiva and Tenon’s Capsule 
Removed  
20 mmHg  
4-7  Conjunctiva and Tenon’s Capsule 
Removed  
10 mmHg  
8-10  Healthy In-vivo  n/a  
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Instruments, Akron, OH). Immediately after completion of the perfusion experiments, the eyes 
were perfusion-fixed with 10% formalin buffered solution. Perfusion pressure is the hydrostatic 
force between the anterior chamber pressure and the pressure within the vessels receiving 
aqueous humor outflow. In this study, a normal episcleral venous pressure of 8 mmHg in living 
eyes was assumed.168 The first two intact eyes were perfused with an anterior chamber pressure 
of 20 mmHg. Since the episcleral venous pressure in a cadaver eye is approximately 0 mmHg, an 
anterior chamber pressure of 20 mmHg produced a perfusion pressure equivalent to an IOP of 28 
mmHg in a living eye. An anterior chamber pressure of 10 mmHg yielded a perfusion pressure 
equivalent to an IOP of 18 mmHg in a living eye.  
In the cadaver model, there is no active circulatory system present to remove aqueous 
humor expelled from the outflow system. We found that fluid gradually accumulates in the 
conjunctiva and Tenon’s capsule when that tissue was left intact on the globe, causing shadows 
obscuring visualization of outflow structures. Therefore, we found that cadaver eyes require the 
removal of these layers prior to perfusion to produce images of equal quality to those obtained in 
unperturbed living eyes.150 The conjunctiva and Tenon’s capsule were dissected in all but the 
first pair of eyes. Four eyes were perfused and imaged at 10 mmHg, and then perfusion fixed at 
10 mmHg. One of these eyes was first imaged at a perfusion pressure of 0 mmHg. One eye was 
perfused and imaged at 20 mmHg. After imaging, it was perfusion fixed at 20 mmHg.  
To validate our SD-OCT images, additional eyes (N=3) from ostensibly non-
glaucomatous donors were obtained from the National Disease Research Interchange. Eyes were 
perfused with mock aqueous humor containing fluorescent tracer microspheres (Invitrogen Inc., 
Molecular Probes, Eugene OR; 0.2 µm; 0.002% volume-to-volume) at 7 or 15 mmHg. Each eye 
was perfusion-fixed with 4% paraformaldehyde and sectioned into quadrants. The tracer labeling 
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pattern within the episcleral vessels was imaged in each quadrant using an epifluorescent 
microscope (Nikon TE-2000E) outfitted with a 1x objective.    
10.2.3 SD-OCT Imaging 
An SD-OCT optics engine (Bioptigen, Research Triangle, Durham, NC) was coupled with a 
wide-bandwidth super luminescent diode array (870 nm center wavelength, 200 nm bandwidth; 
model Q870, Superlum Ltd., Dublin, Ireland). This light source has a coherence length of 1.3 µm 
in tissue. The optics engine allows the user to specify any number of A-scans per frame, as well 
as any number of frames, limited only by system memory. It also allows the user to specify any 
number of sequential A-scans to be acquired in a single location during a raster scan for the 
purpose of averaging and Doppler assessment; also limited only by system memory. One living 
eye was scanned using Doppler so that velocity could be used to distinguish large blood vessels 
from large aqueous humor outflow vessels. Subsequently, two scan protocols were created: one 
optimized for the acquisition of 3D data (the “volume” protocol) and one optimized for 
visualization of individual frames (the “2D slice” protocol). Each eye was scanned twice at the 
limbus, first with a protocol optimized for 3D volumes, and the second with a protocol optimized 
for visualization of 2D slices. For each eye a set of 36 individual radial scan sets were acquired: 
each clock hour imaged at its center, and offset to the left and right. The angle of each set of 
clock hour scans was set so that the center clock hour scan was on a radial ray from the center of 
the pupil (i.e. the 9 o’clock scan was at 0°, the 10 o’clock scan at 30°, the 11 o’clock scan at 60°, 
etc.). The density of the 3D volume scan protocol was limited by system memory, and consisted 
of 512 x 512 A-scans probing a 2 x 3 mm (radial x transverse) area of tissue. This scan protocol 
only moved the 20 µm diameter SD-OCT beam 9 µm between A-scans, thus including a single 
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tissue volume in multiple adjacent samples (oversampling). Acquiring oversampled SD-OCT 
data allowed post processing averaging. The 2D slice protocol consisted of 700 x 20 A-scans 
probing the same sized (2 x 3 mm) area of tissue. Each A-scan of the 2D slice imaging protocol 
was repeated 18 times, and the average of those 18 scans recorded. The final 2 x 3 area of tissue 
image was converted to a uniform 4 x 4 mm image. This method was previously described in 
detail.149,177  
10.2.4 Image Processing 
Raw SD-OCT’s were averaged with a floating 5 x 5 pixel transverse kernel, consisting of 5 
pixels in each of 5 adjacent frames, were used to produce an average dataset, using customized 
software of our own design (Listed in Appendix C). Further image processing was performed 
using Fiji (Fiji 1.44, http://fiji.sc/wiki/index.php/Fiji). Images were imported in raw .bog file 
format after the 5x5x5 “rolling average” function was completed. A “Gaussian blur” filter was 
then applied before converting the image to 8-bit format. Images were resampled to provide a 
1:1:1 voxel aspect ratio in three dimensions; from 512 x 512 x 1024 to 342 x 512 x 342 for each 
2 x 3 x 2 mm volume. Images were then inverted so that the black collector channels appeared as 
white structures and the Fiji “subtract background” filter was applied.  
  Contrast enhancement was applied to both SD-OCT and microsphere fluorescence 
images. An “Enhance Local Contrast” filter was applied followed by introduction of a Gaussian 
blur. Contrast was repeatedly adjusted to isolate small vessels. The “subtract background” filter 
was used to isolate the vessels of interest. Contrast was manually adjusted in both SD-OCT and 
fluorescence images to suppress remaining noise. The SD-OCT 3D volumes were rendered using 
the Fiji 3D viewer plug-in.  
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10.3 RESULTS 
10.3.1 Subjective Observations 
Direct observations of the SD-OCT images revealed components of the superficial ISVP, 
connecting aqueous veins, and SC in all eyes. Confirmation of location was obtained by 
matching vascular patterns seen in the 3D virtual corrosion cast with corresponding B-scan 
cross-sectional images (Figure 42a-d). The superficial venous plexus visualized was composed 
of a series of small, interconnected venules between 25 – 100 µm in diameter with many 
interconnecting branch points forming a dense vascular hexagonal meshwork (Figure 42A). Red 
arrows indicate a vessel seen on the virtual casting (Figure 42A) and its corresponding location 
in B-scan (Figure 42B). Blue arrows indicate a suspected aqueous vein (Figure 42C) descending 
from the superficial ISVP to the midlimbal ISVP and its corresponding location in B-scan 
(Figure 42D). Yellow arrows indicate two suspected aqueous veins seen in this 180 degree 
rotated virtual casting image (Figure 42E). 
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Figure 42. ISVP in 3D and its feeder vessels 
10.3.2 Vessel Size 
The superficial venous plexus visualized was composed of a series of small-
interconnected venules 10 – 50 µm in diameter with many interconnecting branch points forming 
a dense vascular hexagonal meshwork (Figure 44A). Vessels approaching the size of capillaries 
(<10 µm) were assumed to be present, but were not visualized. Vessel diameters were measured 
in the 4 x 4 mm scan according to estimation of pixel number/image volume and compared to 
known measurements from previous physical corrosion casting studies of the eye (Figure 45).  
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Vessel type and diameter was estimated based on the pixel count and image volume and 
compared to known measurements from previous corrosion casting studies of the eye. The 
yellow arrow shows a vessel between 75-100 µm draining into a larger vessel approximately 200 
µm in diameter (Figure 45). Red arrow points to a small connecting vessel between 
approximately 25 µm in diameter.   
 
Figure 43. ISVP size 
For example, in the x direction, each pixel corresponds to a width of 4mm/342. When viewed 
along the long horizontal axis, venous structures are seen to descend into the deeper limbus and 
form branches into midlimbal venous plexus structures, which are also visible in B-scan cross-
sections (Figure 42c-d).   
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10.3.3 Outflow Network Morphology 
The venous plexus was drained posteriorly by several larger veins forming a series of radial 
arcades. These vessels are 50 - 100 µm in diameter and progressively converge into larger 
vessels moving posteriorly away from the image margin and SC (Figure 44, yellow arrows).  
 
Figure 44. A 360-degree virtual casting of a cadaver eye 
The blue arrow in Figure 44 points to an enlarged section with several straight radial 
arcades draining vessels perpendicularly to the limbal margin. Note the dense array of 
vasculature located superiorly, nasally, and temporally with sparser vasculature seen inferiorly. 
The red arrow indicates where the perfusion needle penetrated the cornea (Figure 44).  These 
vessels converge with larger more tortuous vessels, which were rarely observed. These tortuous 
vessels ranged from 200 - 400 µm in diameter (Figure 45, yellow arrow).  
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Figure 45. A large tortuous vessel 
A large tortuous vein, with characteristic striations (seen after image contrast 
enhancement) is shown in Figure 45 (yellow arrow). A smaller venous structure is shown 
draining into the larger tortuous vein (Figure 45 red arrow). The smallest visualized structures 
form a dense vasculature mesh surrounding the large drainage vessels (blue arrow). Unlike the 
radial arcades, large tortuous veins do not travel in a consistent direction in relation to the image 
margin. It is unclear, from these visualizations, where these large tortuous vessels terminate or 
converge.  
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A similar vascular pattern was observed in tracer-perfused eyes (Figure 46),  
 
Figure 46. Fluorescent microsphere labeled outflow system 
where tracer was found to decorate several larger vessels (50 – 100 µm) extending posteriorly 
from the limbus in both raw (Figure 46) and contrast enhanced (Figure 47) fluorescence images. 
Fluorescent microspheres (diameter = 0.02 µm) revealed a meshwork-like network of aqueous 
humor outflow veins.  Figure 47 shows a microsphere labeled outflow system after local 
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histogram equalization and background subtraction filters were applied, revealing visualization 
of a meshwork of outflow vasculature extending into the outflow vascular tree down to 
Schlemm’s canal. (Figure 47) 
 
Figure 47. Enhanced visualization of the outflow vasculature down to Schlemm’s canal.   
Smaller tracer-labeled vessels (30 – 40 µm) were often seen branching between the larger 
vessels, occasionally exhibiting a hexagonal network pattern (Figure 47). There was significant 
variability in tracer labeling around the episcleral limbus, with intense labeling observed in some 
quadrants while other quadrants of the same eye exhibited very little label.  
Nasal and temporal in-vivo scans in three eyes confirmed the vessel morphology 
observed in cadaver eyes. All three previously described vascular structures (venules, radial 
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veins, and large tortuous veins) were visualized in-vivo. Few significant differences were 
observed between in-vivo and ex-vivo virtual castings. Structures in-vivo appeared less consistent 
in diameter than ex-vivo (Figure 48) Direct observations did not show marked differences in-vivo 
(Figure 48A) vs. ex-vivo (Figure 48B), except that in-vivo castings appeared to have a smaller 
average vessel diameter, perhaps due to engorgement of vessels during perfusion ex-vivo. In-
vivo castings are expected to also include arterial blood vessels, which are not active in the 
cadaver eye. 
 
Figure 48. Living versus cadaveric virtual casting 
Doppler studies were performed on one eye in-vivo to confirm flow through a large tortuous 
venous structure (Figure 49). A large tortuous vein (yellow arrow) casts shadows towards the 
anterior chamber (Figure 49A). Several aqueous venous shadows can be seen (brown arrows). A 
contact lens worn during this study is seen (red arrow). The vessel can be seen to have a 
characteristic laminar flow pattern, with slower flow near the edges of the vessel and more 
uniform flow near its center (Figure 49B blue arrow). Slow blood flow increases reflectance and 
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mimics stationary tissue. Color Doppler flow patterns are indicated and overlaid on top of a 
structural scan (Figure 49C). Both blue and red flow patterns are seen in the same vessel due to 
the variable course of the vessel in relation to the OCT scanner resulting in blood flowing 
towards and away from the probe at different areas. 
 
Figure 49. Doppler observed in a living human eye 
The high velocity signature of this vessel, compared to the low velocities within aqueous humor 
outflow vasculature, suggest that this was a blood vessel.  
Qualitative assessment of vasculature density showed dense concentrations of vasculature 
in the nasal and temporal position in all eyes, forming branching arcades that drained into 
progressively larger vessels at increasing distances from the limbus. Similarities were observed 
between 360-degree virtual castings and previous studies using colored silicone casting agents in 
monkey eyes.  
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10.4 DISCUSSION 
10.4.1 Summary of Findings 
We present the first SD-OCT 360 degree virtual casting of outflow microvasculature comprising 
the ISVP, connecting aqueous veins, and components of SC. Our methodology, in contrast to 
physical corrosion casting, is completely non-invasive and may be performed in living human 
eyes. Previous methods used to image the limbal vessels include serial sections with or without 
dye, ultrathin sections, microvascular perfusion with plastics, rubber or silicone and corrosion 
casting, x-ray microcomputed tomography, fluorescein angiography and vascular endothelial 
labeling techniques.190 Of these, only SD-OCT images allows for non-invasive structural 
identification without contrast media, chemicals or ionizing radiation. Further, without the need 
for corrosion, our method allows localization of the various components of the casting relative to 
the surrounding tissue by referring to the corresponding structures within the 2D image stack 
(Figure 44).  
There was excellent agreement between structures visualized with SD-OCT and previous 
casting studies. Vascular morphological structures observed in this study (Figures 52, 53) were 
compared to micro-corrosion vascular castings in the published literature using either Microphil 
or neoprene studies in humans,26-28 methyl methacrylate polymer resin studies with or without 
Mercox injected into blood vessels,192-197 or colored silicone.42,198 In the present study, perfusion 
with fluorescent microspheres was used for further confirmation that the virtual castings created 
with OCT indeed isolate outflow microvasculature (Figures 48 and 49). As with castings in the 
literature, there was excellent agreement between the microvasculature visualized in SD-OCT 
castings and that labeled by the microspheres.   
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A characteristic radial striation was observed in our 3D virtual castings as a series of light 
and dark stripes after contrast enhancement on larger vessels. This correspond with striations of 
similar morphology on venous structures observed in corrosion casts of the eye under high power 
in rabbits199 and rats193,197 and in vessels of the GI tract,200 bladder,201 and cerebral cortex202 in 
humans and biliary tract203 in rat models and were present both in-vivo and ex-vivo (Figure 48). 
Although these striations in micro-corrosion castings may be accounted for by leakage of the 
casting resin to the subendothelial space in corrosion castings,194 we feel it is unlikely these are 
artifact due to the consistent radial pattern along vascular structures often moving in different 
directions relative to the image plane and their presence in multiple previous studies.  
Our SD-OCT hardware has a theoretical axial resolution of 1.3 µm, however no vessels 
less than 10 µm were observed which raised a question as to whether structures smaller than 
venules were present in our findings. Nevertheless, we were able to track the vascular sources of 
the cast structures back to SC, suggesting that vessels of the smallest magnitude in the outflow 
vascular tree were visualized and included in the casting. Vessels smaller than those present in 
our study, if present and connected to SC, may have collapsed post-mortem and were not 
reopened during perfusion due to the higher surface tension within.  
In-vivo vasculature appeared smaller and less distinct than ex-vivo (Figure 50). Ex-vivo 
vasculature may also be artificially larger due to engorgement as part of the perfusion process or 
small eye movement in-vivo may be a factor. Further mathematical schema and image software 
are needed to better determine vasculature size, diameter, and corresponding function.  
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10.4.2 Vessel Identification 
We are confident that at least some structures we observed were venous vasculature 
comprising aqueous humor veins. By tracing vessels in the 2D stack, we could confirm the 
smallest vessels connected directly to SC and we have surrounding tissue in the slice to place the 
actual location of the vessels that we cast. The perfusion process allows enhancement of venous 
structures over arteries due to the preferential outflow through the conventional outflow system 
to the episcleral vasculature which is principally a venous network.204 Previous corrosion casting 
studies utilizing the conventional outflow system also confirm the outflow vasculature is venous, 
not arterial, and no anastomoses could be located between veins and arteries after filling in these 
studies.42,198 Finally, although the superficial limbus contains lymphatic vessels which share 
some morphological similarities to venous networks, visualization of lymphatic vessels generally 
requires separate perfusion in the lymphatic system.190  
Doppler studies were performed on one eye in-vivo to provide further evidence of venous 
outflow (Figure 51). The large Doppler signal visible in this vessel, compared to smaller signals 
in surrounding vasculature, suggest that this vessel is likely part of the blood flow system, 
possibly a terminal drainage vein in the aqueous outflow vascular tree. The vessel can be seen to 
have a characteristic laminar flow pattern, with slower flow near the edges of the vessel and 
more uniform flow near its center. Slow blood flow increases reflectance and mimics stationary 
tissue.  
 A 360-degree virtual casting is compared to a casting using silicone198 and shares many 
similarities (Figure 52). Vascular density appears highest temporally, superiorly and nasally in 
the virtual casting with less dense arcades noted inferiorly. The authors concede that, at present, 
there is no universally accepted method of quantifying vasculature structures in 3D SD-OCT 
 136 
virtual castings so we cannot comment with absolute certainty that all vessels are being 
observed. Further methods of quantifying our findings, including using corrosion casting 
techniques or histological sectioning are needed to confirm whether preferential outflow based 
on density of vasculature exists in the human eye ex-vivo. Ultimately, application of virtual 
castings will depend on determination of how each of these potential parameters is affected by 
the presence of glaucoma.   
10.4.3 Study Limitations 
Limitations of the study included the lack of direct comparison between virtual castings and 
histological castings currently in progress. Additionally, although we created a custom mount to 
limit eye movements in vivo, we could not completely eliminate these from our in vivo castings. 
Finally, non-isotropic pixel aspect ratio refers to the fact that our pixels may not be exactly 
square in "real" space. We estimated vessel size based on the pixel count knowing that in the x 
direction, each pixel corresponds to a width of 4mm/342. Development of an algorithm to 
measure pixels with a standardized pixel size from the anterior eye may give us more specific 
estimates of vessel size.  
10.4.4 Conclusions 
We present the first detailed morphometric analysis of small aqueous humor outflow structures 
obtained non-invasively in-situ using SD-OCT.  Continued development of this technique may 
lead to clinically useful direct assessment of outflow in subjects with glaucoma.  
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11.0  VALIDATION OF DOPPLER MEASUREMENTS IN-VITRO 
11.1 INTRODUCTION: ARE SD-OCT MEASUREMENTS OF DOPPLER 
ACCURATE? 
In Chapter 4, the presence of Doppler within vessels observed to emanate from Schlemm’s canal 
was one piece of evidence identifying those vessels as collector channels.  Specifically, the 
direction of flow within the vessels demonstrated flow out of Schlemm’s canal.  The detection of 
Doppler introduces the potential to go beyond mapping the outflow system, but with the 
combination of structural (mapping) and functional (Doppler) imaging, to use SD-OCT 3D 
imagery to calculate volumetric outflow.  Before using Doppler measurements in flow 
calculations, Doppler measurements obtained by SD-OCT must be validated.  In this chapter, an 
in-vitro model utilizing a glass tube and turbid liquid is used to validate SD-OCT’s ability to 
accurately measure flow at known rates.  Limitations of the device are also revealed and 
discussed. 
OCT is a ranging technique based on low coherence interferometry which has been 
applied to structural imaging of the eye.91 SD-OCT utilizes advances in broadband low 
coherence light sources and high speed linear array detector technologies, acquiring complete 
1024 pixel A-scans in a single spectrometer measurement.95,205 Reflectance intensities are 
frequency encoded in the raw SD-OCT fringe pattern.  Fourier analysis of SD-OCT yields more 
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than just reflectance data.  Doppler signals from all points within the reflectance data set are also 
produced, and have recently been used to measure retinal blood flow.206,207 The real (or power) 
component of the Fourier transform of SD-OCT data produces an A-scan, and Doppler 
measurements are contained in the imaginary (or phase) component.206-208 But, the dynamic 
range of SD-OCT Doppler measurements is limited to low velocities by spectrometer limitations. 
High velocities produce large Doppler shifts that physically manifest as rapid translation 
of the associated carrier frequency across the face of the spectrometer.  Because of this, both 
structural measurements of moving back scattering sources and SD-OCT Doppler measurements 
are limited by the A-scan rate, which limits the CCD’s ability to capture moving carrier waves 
without blur.207 The purpose of the present study was to validate SD-OCT Doppler velocity 
measurements under well-controlled conditions in an in vitro laminar flow model. 
11.2 METHODS 
11.2.1 Experimental Setup 
A 30cc syringe was filled with skim milk and inserted into a syringe pump (Perfusor® basic, B. 
Braun Medical Inc., Bethlehem, PA).  Flow rates were set in terms of the amount of time to 
empty the syringe.  The slowest available settings were used in this experiment, keeping them 
within a range relevant to measurements in retinal vessels. The pump used flow settings of 
minutes per 30 cc’s.  Based on the volume of the capillary tube, pump settings produced the flow 
and velocity rates listed in Table 10. 
 139 
Table 10. Flow pump settings, velocity, and flow rates 
 
 Intravenous (IV) tubing connected the syringe within the pump to a glass capillary tube 
(internal diameter = 0.579mm; Yankee 20λ disposable micropipette, Becton Dickinson and Co, 
Parsippany, NJ) shallowly embedded in agarose gel.  IV tubing then carried the milk to a 
collection reservoir (Figure 50).  Skim milk was pumped at controlled rates from a 30cc syringe 
pump, through a glass capillary tube embedded in a shallow bed of agarose gel (Figure 50 top).  
The capillary tube was oriented at approximately 83º to the scanning beam.  The 3D scan volume 
contained a series of axial slices acquired along the length of the capillary tube. 
 The orientation of the milk column within the 3D scan data was used to determine the 
Doppler angle relative to the interrogating SD-OCT beam.  All measurements were performed 
with the capillary tube in a single location and the Doppler angle remained constant throughout 
the experiment.   
Pump Setting
(min)
Flow Rate 
(ml/min)
Mean Velocity 
in Tube
(mm/sec)
Peak 
Velocity 
in Tube
55 0.55 35.0 70.0
50 0.6 38.5 77.0
45 0.67 42.8 85.6
40 0.75 48.1 96.2
35 0.86 55.0 110.0
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Figure 50. In-vivo Doppler model setup 
11.2.2 Imaging 
All imaging was performed using a customized SD-OCT consisting of an anterior segment eye 
scanner and optics engine (Bioptigen Inc., Research Triangle Park, NC) coupled with a 3-diode 
100nm bandwidth broadband superluminescent diode (T-840, Superlum, Co. Cork, Ireland).  
This configuration yields a theoretical axial scan resolution of 3.5µm in medium.  CCD 
integration time was set at 35 microseconds, yielding an A-scan frequency of 28,571 Hz and a 
Nyquist limit of 14,285 Hz for Doppler shifts.  The velocity associated with this limit is a 
function of the center wavelength of the SD-OCT light source, the medium in which flow occurs, 
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and the angle of the velocity vector relative to the SD-OCT beam,206 and is calculated as shown 
in equation 5.   
Equation 5. SD-OCT Velocity Equation from Doppler Shift 
 
 In water (refractive index = 1.33), and with velocity oriented perpendicular into the beam 
(angle = 0, cosine (0) = 1), an 870nm centered light source sampled at 28,000 Hz has a Doppler 
velocity Nyquist limit of 4.58 mm/sec.206 Doppler shift measurements were recorded on a 16-bit 
scale.  The center of the scale (32,767) represents a Doppler shift of zero.  Negative Doppler 
shifts are evenly distributed from 32,766 to zero, with zero being the negative Doppler Nyquist 
velocity.  Positive Doppler shifts are evenly distributed from 32,768 to 65,535, with 65,535 
being the positive Nyquist Doppler limit.  Thus, Figures 51 and 52 display Doppler samples with 
background noise fluctuating around 32,767 (0 Doppler).  Doppler images were processed using 
ImageJ (ImageJ 1.38X, National Institutes of Health, USA).  In Figure 51, velocity profiles at the 
location of Nyquist velocity (A) and through the center of the flow image (B) are shown. Note 
the random appearance of Doppler signals within the phase-wrapped and fringe washout center 
velocities (Figure 51B).  The yellow line marks the location of velocity profile, and the red line 
marks the level of 0 Doppler shift.   
Angle)rCos(DoppleIndexfractiveRe2
WavelengthCenterFrequencyDopplerVelocity
××
×
=
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Figure 51. Doppler shift and velocity profile maps. 
Examination of the Doppler signal (Figure 52A) suggests that phase wrapped twice in this 
measurement, i.e. the maximum center velocity is greater than two times the Nyquist velocity.  
Smoothing failed to produce a velocity profile (Figure 52B) that could accurately be measured.  
The red line (Figure 52) marks the level of 0 Doppler shift.  The region in Figure 52 highlighted 
in blue is the background noise, consisting of random Doppler signals from the stationary glass 
tube, and the region highlighted in red is the Doppler flow under and up to the Nyquist limit.  
The region fading from green to white is the flow signature beginning at a measureable level of 
phase wrapping, but fading to noise due to fringe washout.  The appearance of the light center 
(Figure 52) suggests that a second Nyquist limit may have been passed, however the noise 
observed in the velocity profile suggests that the signal has degraded beyond a useful level. 
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Figure 52. Doppler shift noise versus signal 
A-scan density of 128 x 128 A-scans was spread over a 4 x 4 mm area, and each A-scan was 2 
mm in length.  Fifteen sequential stationary A-scans were obtained at each of the 128 x 128 
positions, and Doppler shifts calculated from temporal changes in phase. 
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11.2.3 Measurement Validation 
The model produced laminar flow at well-controlled rates.  This means that the velocity 
throughout the tube was known because of the parabolic velocity distribution.  With this 
knowledge, it was possible to determine exactly where the velocity would surpass the upper limit 
of the measurement device.  This location was calculated for each flow rate used in the 
experiment.  The known and measured location of the Nyquist limit velocity within the flow 
profile was compared.  Specifically, expected and observed proportions of usable signal at each 
flow level were compared by Wilcoxon signed-rank comparison.  Expected values were 
regressed against known values created by the model.  P < 0.05 was considered statistically 
significant. 
 
Figure 53. Presentation of phase-wrapping without fringe washout 
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11.2.4 Subjective Observations 
In all reflectance and Doppler images, a clear laminar flow pattern was observed, with maximum 
velocity appearing in the center of the flow column, and an apparent parabolic velocity 
distribution observed in the “bull’s-eye” pattern of the Doppler image, and the non-phase-
wrapped portions of the cross-sectional velocity profiles (Figure 53).  Phase wrapping was 
observed (Figure 53).  In Figure 53, the outer circle represents flow below the Nyquist limit, and 
the portion of the velocity profile below Nyquist has a length of 2 (1+1), out of a total length of 5 
(1+3+1).  Thus, 40% of the velocity profile occurs below the Nyquist limit.  The predicted 
percentage of flow below Nyquist was used as the outcome parameter.  The velocity profile 
(Figure 53 bottom) is obtained at the yellow line.   
11.2.5 Doppler Imaging and Flow Orientation 
Clear, well focused 3D reflectance and Doppler domain image sets were successfully recorded at 
mean flow speeds of 35.0, 38.5, 42.8, 48.1, and 55.0 mm/sec.  The position of the fluid column 
relative to the scanning beam was determined by locating two points on the column in space: x1, 
y1, z1, and x2, y2, z2.  Specifically, these points were identified on two different slices (x1 and x2, 
Figure 54) widely spaced within the 3D data set.  The length of the tangential component (Figure 
54) was calculated as  
Equation 6. Tangential magnitude from Cartesian coordinates 
 
and the measured component as z2-z1.  The angle between the beam and flow vector was equal to 
 
( ) ( )2221 12 yyxxTangential −+−=
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Equation 7. Doppler angle 
 
The orientation of the tube velocity vector relative to the illuminating laser was computed, 
yielding a Doppler angle of 83.24º (Figure 54). 
 
 
Figure 54. The position of the fluid column from two frames 
 
Because the measured component of the flow vector was oriented away from the illuminating 
laser beam, Doppler shifts were negative.  Reflectance within the flow column decreased with 
⎟
⎠
⎞
⎜
⎝
⎛−
measured
Tangential1tan
 147 
increasing velocity (Figure 55).  Fringe washout occurred in the experimental setup, resulting in 
the loss of signal from milk moving at velocities similar to those known to exist in the large 
vessels of the eye (Figure 55 bottom).    
 
Figure 55.  Examples of fringe washout 
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11.2.6 Phase Wrapping 
Phase wrapping was observed at all measured flow velocities.  The Nyquist velocity, or location 
of phase wrap, was observed at the point where black Doppler velocity signal becomes white 
abruptly (Figure 51).  Velocity profiles were created at the Nyquist frequency (Figure 51A), and 
through the center of the Doppler image (Figure 51B).  Smoothing (3x3 averaging kernel) of the 
Doppler image (Figure 52) failed to produce a recognizable phase-wrap signal as presented in the 
theoretical Figure 56.  Under ideal conditions, Doppler signals would be below the Nyquist limit 
(Figure 56A).  If the Doppler signals exceed the Nyquist limit (Figure 56, arrows), phase 
wrapping will occur, and a velocity pattern similar to (Figure 56B) is expected.  The red line in 
Figure 56 marks the level of 0 Doppler shift. 
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Figure 56. Appearance of velocity profile in ideal phase wrapping 
 150 
11.2.7 Doppler Validation Below Nyquist 
There was no statistically significant difference between predicted and observed percentage of 
signal below Nyquist.  The observed percentages of the velocity profile at or below Nyquist 
frequency was highly correlated with the predicted percentages (R2=0.934, p=0.007; Table 11).  
Table 11. Predicted and observed Nyquist location 
 
11.3 DISCUSSION 
11.3.1 Summary of Findings 
In the present study, we found that Doppler measurements, when performed within the 
measurement limits imposed by optical and scan parameters, was in excellent agreement with 
known values.  However, as velocities increased above the Nyquist limit and phase wrapping 
was observed, fringe washout reduced both reflectance and Doppler signals resulting in the 
degradation of Doppler signal to noise.  It is possible to limit assessment to locations where flow 
is below Nyquist (Figure 51A).  Reflectance images display phase wrapped flow as regions 
Mean 
Velocity
(mm/sec)
Predicted 
Percentage 
Below Nyquist
Observed
Percentage
Below Nyquist
35.0 47.86% 44.28%
38.5 41.86% 40.27%
42.8 36.40% 37.80%
48.1 31.43% 31.68%
55.0 26.75% 23.59%
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without observable reflective sources; thus blood vessels typically present as black spaces in 
OCT images.  Doppler images display phase wrapped flow fields as areas containing stark black 
to white (or red to blue in color images) circles of transition surrounding a salt and pepper 
appearing area of pure noise (Figures 52 and 55). 
11.3.2 Phase Wrap and Fringe Washout 
SD-OCT is capable of measuring Doppler shifts throughout each A-scan, but large Doppler 
shifts induce phase wrapping (Figure 55).207 Given laminar flow in the present study, it might 
appear that phase unwrapping techniques could recover the actual velocity profile at velocities 
above the Nyquist limit.209 However, progressive signal degradation after phase wrapping may 
prevent recovery of the true velocity signal.  Within the fringe pattern, Doppler shifts physically 
manifest as a lateral drift across the CCD within the spectrometer.  Faster velocities produce 
larger Doppler shifts resulting in faster drift.  These drifts only occur within the frequency 
components associated with the location of the source of the Doppler shift, leaving other 
frequencies for the most part unaffected.  If this drift is fast enough, fringe washout occurs.210 
Specifically, several peaks and troughs move across individual CCD pixels within the integration 
time of the camera, resulting in destructive interference and signal loss.  This is the reason that 
large blood vessels appear to be black within the center. The phase unwrapping techniques 
referenced previously may be useful in situations where Nyquist limit violations result in strong 
but erroneous signals, however in the case of SD-OCT Doppler measurements, excessively high 
Doppler shifts result in signal drop-out, leaving only noise in the measurement.  
 It might also be thought that given valid velocity measurements in the low velocity edge 
of the flow column, the actual flow distribution might be recovered by modeling the available 
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accurate measurements to a parabolic flow distribution.  This technique was employed in the 
present study to predict the location in the flow column at which phase wrapping would occur.  
This technique is only applicable to biological systems if laminar flow is known to exist. When 
flow is laminar, the mean velocity is equal to half of the maximum velocity; the mean velocity in 
a turbulent flow system is equal to the mean.  Studies of blood flow in glass tubes with diameters 
similar to those of retinal vasculature suggest that velocity was 1.6 times greater than the 
mean,211 suggesting that flow in the retinal vasculature is neither purely laminar nor turbulent.  
Fitting measurements to a parabolic distribution would be invalid in either type of vessel.   
The findings in the present study suggest that the current setting of SD-OCT is of limited use in 
biological systems.  The Nyquist limit of 4.58 mm/sec of the system used in this study is typical 
for SD-OCT configurations using currently available linear array camera technologies. This limit 
is far less than the peak arterial blood velocity in retinal arteries.212  In order for arterial velocity 
to be scaled down by geometry, specifically the cosine term in the Doppler velocity equation, to 
be measurable by SD-OCT, the flow vector (i.e. the artery) would need to be oriented within 
approximately 4° of perpendicular to the beam.  However, the present system’s setting is 
appropriate and useful for the measurement of very small velocities such as that in the retinal 
capillaries, or in the aqueous drainage vasculature.   
11.3.3 Conclusions 
SD-OCT provides objective Doppler measurements of laminar fluid flow in an in vitro flow 
system in a range up to the Nyquist limit.  Efforts to obtain velocity measurements above the 
Nyquist limit may be impeded by the severe loss of data quality in the phase-wrapped range of 
velocities.  These limits exclude measurements in large retinal vessels, but allow accurate 
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assessment of slow velocity systems such as retinal or anterior segment capillaries or the aqueous 
drainage system. 
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12.0  VALIDATION OF DOPPLER IN IN-VITRO SD-OCT SCANS OF THE 
AQUEOUS HUMOR OUTFLOW SYSTEM 
12.1 INTRODUCTION 
Measuring flow has a number of medical, research and industrial applications. The use of 
Doppler ultrasound213 and laser flowmetry214 has changed the way medicine is practiced and our 
understanding of physiology215. However, low velocity flow fields are often not visible.  It would 
be advantageous if these flow fields could be made visible, facilitating measurement, without 
perturbation.  In the previous chapter, the ability of SD-OCT to measure Doppler, as well as its 
limitations, were demonstrated.  Here, Doppler measurements are applied to aqueous humor 
outflow cadaver model eyes. 
SD-OCT is conventionally used as an imaging technique for high-resolution structural 
scans of optically turbid tissues91,216. Recent increases in acquisition time makes OCT a 
promising device for detecting microscale flows217. Previous work demonstrated OCT’s ability 
to detect blood flow in the human retina218, skin219 and the heart.220 
Only fluids containing scattering media at the wavelength of the OCT light source will 
show a Doppler shift. A number of physiologically relevant flows, such as that of the aqueous 
humor, lymphatics, synovial fluids and cerebrospinal fluid may not show a distinct Doppler 
signal. Aqueous humor is of particular relevance to glaucoma because the balance between its 
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production and outflow controls intraocular pressure. Elevated intraocular pressure is the primary 
risk factor for the presence and progression of glaucoma, an optic neuropathy that is the second 
leading cause of blindness worldwide48. Improving our understanding and measuring aqueous 
outflow is an important process in understanding glaucoma. 
Nanoparticles have increasingly been used in areas of medicine as well as industry. 
Magnetic nanoparticles have been used as an MRI contrast agent and anti-cancer heating 
agent221. Nahrendorf et al222 demonstrated the use nanoparticles to enhance contrast on 
macrophages in atherosclerotic plaques. Oldenburg et al223 established the use of gold nanorods 
as a structural contrast agent for OCT. OCT Doppler imaging has been previously used to detect 
movement of magnetic nanoparticles224. 
Despite the use of nanoparticles as structural contrast, the use of nanoparticles as 
functional contrast to increase visibility of a physiological process has not been reported. This 
chapter describes the use of plasmon resonant gold nanorods as a functional contrast agent for 
OCT and demonstrates an application by imaging ex-vivo the anterior outflow pathway of 
porcine and human eyes. 
12.2 METHODS 
12.2.1 Titration 
A concentrated polyelectrolyte sodium salt coated plasmon resonant GNRs (60nm length 12nm 
radius, nanorods LLC) was titrated with deionized water to different concentrations. The 
concentrations scanned were: 0.3, 0.4, 0.5, 0.7 and 1 x 1012 GNRs/mL. Concentrations were 
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increased until a subjectively strong Doppler signal was observed throughout the entire flow 
field.  
Doppler scans (2mm x 3mm x 2mm, 700 x 20 x 1024) were acquired using SD-OCT 
(Bioptigen, Durham, NC) while the fluid was stationary within a capillary tube with a radius of 
0.32mm. 12 Doppler frames were acquired for analysis with an acquisition rate of 28kHz, 
resulting in a Nyquist limit of 4.62mm/s normal to the scanning beam. Doppler and structural 
scans were analyzed to determine the concentration at which it was possible to scan through the 
volume of the tube while maintaining Doppler signal. 
12.2.2 Validation 
A 0.7x1012 GNRs/mL solution mixed with deionized water was passed through a glass tube with 
radius 0.32mm. The glass tube was suspended 45 degrees to the direction of the OCT scanning 
beam. The angle to the scanning beam was independently confirmed on the structural scans in 
SD-OCT. 
The GNR solution was pumped at a volumetric rate of 0.335mL/min with a constant 
pressure perfusion system. Flow rate was measured by changes in the weight of solution 
remaining in a reservoir. Doppler scans (2mm x 0.4mm x 2mm, 700 x 20 x 1024) were acquired 
using SD-OCT (Bioptigen). 
12.2.3 Ex-Vivo Porcine Outflow Model 
Three cohorts porcine eyes were warmed to 40 degrees Celsius then perfused in the anterior 
chamber with a) mock aqueous alone (control, n = 6) and b) 1x1012 GNRs/mL solution with 
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mock aqueous (n = 3). The eyes scanned within 16 hours of death. A DATAQ acquisition unit 
recorded rate of perfusion in the constant pressure perfusion system. Of the three eyes perfused 
with GNRs, the aqueous humor within the anterior chamber was replaced with GNR solution at 
the start of perfusion in the final 2 eyes.  
A 27-gauge perfusion needle was inserted through the cornea, between the lens and the 
iris. The tip of the needle was placed near the ciliary muscle, the physiological site of aqueous 
production. The needle was inserted into the nasal side for all eyes. Before imaging GNR 
solutions flowed under constant pressure for 20 minutes to allow outflow to stabilize. Doppler 
scans (700 x 20 x 1024) were taken over a 4mm x 4mm x 2mm area with 12 repeated scans using 
OCT. Samples of the mock aqueous and GNR solutions used in these perfusion experiments 
were scanned using a spectrophotometer to determine exact optical density (used to confirm 
concentrations). 
Flow rates were calculated by identifying all observed Doppler signals within the 360° 
SD-OCT scans, calculating the velocity in that position, measuring cross-sectional outflow 
vessel area in the associated structural image at that location, and calculating flow.  Total 
volumetric flow was calculated as the sum of observed flow in the limbus.  Paired flow and 
structural images are described in the previous chapter. 
12.2.4 Ex-Vivo Human Outflow Model 
The same model described above for the porcine eye was used for the human eye.  As with the 
second two porcine eyes, the aqueous humor in the anterior chamber of the human eye was 
replaced with GNR solution via a second needle paracentesis.  The GNR concentration was 
increased to a 3:10 GNR/mock aqueous solution concentration.   
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12.3 RESULTS 
12.3.1 Titration 
GNRs created a visible Doppler signal across a range of concentrations: 0.3, 0.4, 0.5, 0.7 and 1 x 
1012 GNRs/mL. The optimal concentration of GNRs for enhanced Doppler signal without the 
creation of obstructive shadows in the structural image was 0.7 x 1012 GNRs/ml. All Doppler 
scans of different titrations are shown in Figure 57. 
 
Figure 57. Doppler scans of non-flowing nanorods at a) 0.3, b) 0.4, c) 0.5, d) 0.7 and e) 1x1012 GNRs/mL 
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12.3.2 Validation 
The OCT Doppler cross-sectional scan through the 0.7 x 1012 GNRs/mL solution is shown on 
Figure 58. A theoretical velocity profile was calculated based upon the flow measured by the 
perfusion system and superimposed on the Doppler velocity profile in Figure 59. The difference 
between predicted and observed velocities is presented in Figure 60. 
 
Figure 58. Doppler image of GNR solution flow field (0.7 x 1012 GNRs/mL) 
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Figure 59. Theoretical versus actual velocities 
 
Figure 60. Difference between predicted and observed velocities 
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12.3.3 Ex-Vivo Porcine Eye Model 
With mock aqueous alone, the Doppler signal in the pig anterior chamber (Figure 61) was 
weak. The addition of GNRs increased the contrast within vessels and showed clear Doppler 
signals in Figure 61. The velocity profile of the Doppler scan, in Figure 62, shows laminar flow 
within the vessels. 
 
Figure 61. Doppler and structural OCT of the outflow drainage system in porcine eyes perfused with a) 
mock aqueous and b) 1 x 1012 GNRs/mL with mock aqueous. 
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Figure 62. Velocity profile of the GNR enhanced Doppler scan in a porcine eye 
Doppler scans of the first of the three GNR porcine eyes produced no discernable Doppler signal.  
The known flow rate based on the change of reservoir weight over time was 3.42 µl/min.  
Integrating observed Doppler signals over the limbus of the second porcine eye yielded a 
calculated flow rate of 4.41 µl/min in the Doppler SD-OCT scans for eye 2.  The known flow 
rate for the second eye based on the change in reservoir weight over time was 6.25 µl/min.  The 
third eye and had a SD-OCT measured flow rate of 7.31 µl/min and known flow rate of 7.02 
µl/min.   
12.3.4 Ex-Vivo Human Eye  
 Observed Doppler signals in the human eye did not yield sufficient Doppler signals to 
produce a measurement. Figure 68 shows a large deep vessel (yellow arrows).  Since this is a 
cadaver eye, it is likely that the vessel is open due to the pressure of the mock aqueous GNR 
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solution within the anterior chamber and outflow system.  Despite the likely presence of GNR 
solution, the Doppler signature in this region is characteristic of pure noise (Figure 63, yellow 
arrow right).  Some small traces of consistent Doppler signal were observed.  Figure 64 shows 
the structural and Doppler images with a small region featuring a consistently small white path in 
the region of an aqueous vein (yellow arrows).  Figure 65 shows a magnified view of the same 
region.  Note that the Doppler signals within the region correspond to the visibly open portions 
of the aqueous vein.  It was previously shown (Figure 16, chapter 5) that the SD-OCT slice may 
either contain both septa and internal open spaces, or in this case, may only intersect with 
portions of a tortuous vessel.  Figure 66 shows the velocity profile of a line extending throughout 
the limbus, and intersecting a portion of the white Doppler signal.  Note the scale of the graph.  
In 16-bit space, positive Doppler shifts are encoded with values between 32,768 and 65,535 (at 
the Nyquist limit).  With a surrounding Doppler shift level of approximately 32,700, the peak 
shift in this sample is only 38,000, representing a velocity of 0.74mm/sec; assuming that the 
velocity is vertical in the image at the point of measurement.  Figures 67 and 68 show another 
location where consistent Doppler shifts were observed, but with much smaller intensities and 
corresponding velocities.  Figure 69 shows what appears to be a large measurable velocity 
profile in a large superficial vessel.  Note that the velocity is largest at the center, and trails off at 
the edges, suggesting laminar flow.  However; examination of the region of active Doppler as a 
whole shows the salt and pepper pattern characteristic of noise.  It is difficult to determine if the 
observed consistent area of positive Doppler signals truly represent a true signal, or just a 
fortunate gathering of noise.  The presence of and scattered locations of negative Doppler signals 
within a field of positive shift suggests that this is noise, and that numerous velocity profiles 
must be made and examined before allowing this vessel to be included in a flow measurement. 
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Figure 63. Large vessels had a Doppler signature of noise (see porcine Figure 61 A above) 
 
Figure 64. Some small regions presented with consistent Doppler signal, but in very small areas. 
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Figure 65. A magnified view shows that the regions of white Doppler signal correspond to the dark open 
spaces within the outflow vessel. 
 
Figure 66. The Doppler signal within the small vessel is minimal but detectable and larger than 
background scatter. 
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Figure 67. Another slice displayed two regions of small negative Doppler with signals of a similarly small 
magnitude. 
 
Figure 68. The second Doppler region signal 
 167 
 
Figure 69. Despite containing a large measureable Doppler signal, this region may be noise as suggested 
by the salt/pepper Doppler pattern. 
12.4 DISCUSSION 
12.4.1 Summary of Findings 
This study demonstrates the first use of gold GNRs for the purpose of enhancing a functional 
signal with OCT. An optimal concentration of GNRs was identified to maximize penetration 
without losing signal. The use of GNR to enhance Doppler OCT was validated in an experiment 
with known flow parameters. Finally, the use of GNRs and Doppler OCT was demonstrated ex-
vivo in porcine eyes, providing the first Doppler OCT scans of anterior chamber outflow. The 
result was an accurate measurement of aqueous humor outflow with SD-OCT in the porcine eye.  
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While GNRs successfully infiltrated the porcine outflow system, they failed to flow through the 
human outflow system in sufficient concentration to produce a measureable Doppler signal. 
The tradeoff between signal strength and depth of penetration plays an important factor in 
the optimal GNR concentration. As seen in Figure 62, the Doppler signal was strong at 0.7x1012 
GNRs/mL while maintaining the ability to scan through the entire tube. However, once 
concentration increases to 1x1012 GNRs/mL, there is an increase in Doppler noise as the A-scan 
penetrates the solution.  
As the OCT scanning beam traverses the solution, scattering and absorption reduces the 
signal-to-noise ratio of the system. Increasing GNR concentration will increase the quality of 
Doppler signal. However, the OCT system will experience lower depth of penetration. Due to the 
small size of vessels present in the anterior chamber, a 1x1012 GNRs/mL solution was used to 
perfuse the ex-vivo porcine eye for two reasons. First, the solution will mix with aqueous humor 
already present in the anterior chamber, reducing its concentration. Second, higher GNR 
concentrations should not cause a large signal loss because typical vessel size in the anterior 
chamber is approximately an order of magnitude smaller than the glass tube. Therefore, depth of 
penetration is less of an issue in the ex-vivo porcine experiments.   
A comparison between theoretical and actual flow measurements validates the use of 
GNR to enhanced Doppler signals. Figure 59 demonstrates GNR’s ability to measure Doppler 
signal. As expected, noise level increased as the scanning beam penetrates a single line scan due 
to increased absorption and scattering as the light passes through the solution. A comparison of 
error with respect to a theoretical in Figure 58 demonstrates that the measured velocity profile is 
representative of the theoretical with a center at 0.192±0.498mm/s. Figure 60 shows that in the 
histogram, the distribution of the error is relatively normal. However, the histogram has a left 
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skew. This systematic error may result from slight vibrations during the scanning procedure, 
resulting in an alternating pattern on the Doppler scans. 
GNRs’ potential to enhance Doppler signals is demonstrated in the ex-vivo porcine 
model. Prior to scanning, a mix of GNR and mock aqueous was tested to insure that it does not 
alter the functional properties of the nanorods. Figure 66 shows that the Doppler signal was weak 
in the porcine eye perfused with mock aqueous alone. All vessels perfused with mock aqueous 
appear dark on the structural scan, showing little reflectivity. Doppler scans of the same region 
show pure noise. Adding GNRs substantially improved the contrast in the Doppler scans (Figure 
61). The flow profile (Figure 62) appears to be laminar, with maximum fluid velocity occurring 
near the center. This suggests that the Doppler signal within the area is not just an imaging 
artifact. Further, the agreement between the measured and known flow rates in the porcine eye 
support validity of the Doppler signals within the SD-OCT scans. 
Doppler signals were not visible in the human eye despite high perfusion pressure and 
high concentration.  Previous experience in mouse eyes with the same batch of GNRs suggests 
that they are prone to sticking to tissue and to each other.  It is possible that the GNRs used in 
this experiment failed to pass through the trabecular meshwork of the human eye.  Since the 
present study was performed, triple coated GNRs have been injected in the mouse model, and no 
longer appear to stick to internal structures.  Triple coated GNRs will be used in future trials in 
human eyes with hopes of improving penetration into the distal outflow structures.  
There are several limitations to the present study.  Although the scanning process is non-
invasive, current methods of inserting GNRs into the eye are invasive. A non-invasive delivery 
vehicle would help make GNRs more clinically relevant. Theoretically, GNRs can pass through 
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the cornea. However, GNR eye drops would limit our ability to control the concentration within 
the eye. In its current form, GNRs are still useful as a research tool. 
Addition of GNRs had the side effect of decreasing the structural contrast. Normally 
(Figure 61) outflow vessels have little reflectivity. This is in stark contrast to the tissue, which 
has varying degrees of reflectivity depending on the tissue type. GNRs have the unintended side 
effect of reducing structural contrast in the OCT image. While it is possible to distinguish vessels 
from tissue, the boundaries were less defined.  
12.4.2 Future directions 
For research purposes, this paper presents a method for non-invasively imaging flow at a 
microscale using OCT in fluids with little reflectivity. For the applicability of GNRs and OCT, 
other physiologically relevant flows with low Doppler signal must be identified. GNR may be 
useful for enhancing current understanding of lymph, CSF or synovial fluid exchange. There 
may also be potential industrial applications with measuring velocities of microfluids without 
disturbing the system.  
12.4.3 Conclusion 
This paper demonstrates the ability to measure Doppler signals using GNR enhanced 
Optical Coherence Tomography. The optimal concentration of GNRs for Doppler enhancement 
without shadowing is approximately 0.7x1012 particles/ml. The technique allows us to visualize 
aqueous humor outflow in a constant pressure porcine model, which may lead to increased 
understanding of glaucoma pathogenesis. This technique enables the first successful 
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measurement of volumetric aqueous humor outflow by SD-OCT Doppler scans in the pig eye 
model.  Combining OCT with GNRs may provide a useful tool for looking at flow at a 
microscale in experimental medical and industrial applications. 
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13.0  SUMMARY AND FUTURE WORK 
When the work contained herein began in 2007, the aqueous humor outflow system had never 
been visualized with OCT, SC measurements were only feasible in histological sections, and 3D 
visualization of the distal outflow system was only possible with physical corrosion castings in 
cadaveric eyes.  Beyond demonstrating the feasibility of these measurements non-invasively in 
the living human eye, their reproducibility has also been documented.  Non-invasive mapping of 
the human aqueous humor outflow system promises to be an important new implement in the 
armamentarium of the glaucoma specialist.   
In order to move forward with the combined use of Doppler and mapping for aqueous 
humor outflow volumetric measurements, a usable cadaver eye model must first be established 
for validation and calibration of the technique.  Results from the porcine eye are promising, 
which was the reason for moving forward with human eye flow models with GNRs.  However, it 
is likely that the differences between the porcine and human outflow anatomies resulted of the 
failure of previous generation of GNRs to reach the distal outflow structures and provide a 
Doppler signal.  Studies with an improved GNR are ongoing.  Should those fail, it may be 
necessary to perfuse the GNR solution directly into SC in order to observe its passage through 
the distal outflow vasculature at known rates.  In either event, validation will precede 
applications in living human eyes.   
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Future studies will include examining the effect of the most common implant devices and 
glaucoma surgeries on the aqueous outflow system. The reason that a question as simple as 
“what happens to the outflow system when this tube is implanted?” remains unanswered is 
because it could never before be measured.  The ability to finally see SC and the distal outflow 
vessels has opened an entirely new field of ophthalmic research.  To that end, the basic clinical 
questions such as differences associated with disease, the effects of medications, or just a 
description of the normal healthy system across a range of ages all remain to be studied. 
One of the most exciting and promising findings was the fact that differences in IOP 
could be directly observed in the morphology of SC.  This introduces the possibility of not only a 
series of studies on the normal and glaucomatous outflow system response to IOP elevation and 
reduction, but also a potential test useful in the management of the disease.  In the living human 
eye, brief elevation and release of IOP produce a pressure lower than the initial baseline.  
Scanning SC and the outflow system before and immediately after IOP elevation should allow its 
examination at two pressure levels at a single visit in the clinical setting.  This has never before 
been done, and may provide important information concerning the outflow system’s ability to 
compensate for changes in pressure, as well as demonstrating the expected morphological 
response to medicinal IOP reduction apriori.  This study is ongoing in normal eyes. 
In conclusion, the aqueous humor outflow system remains beyond the view of the 
glaucoma specialist.  Laser procedures are performed with no knowledge of the condition of the 
outflow pathway distal to the locations of laser injury. It is possible that a foreknowledge of 
locations of patent collector channel ostia within SC would allow the surgeon more precise 
placement of laser treatments, increasing the efficacy of the procedures.  Similarly, penetrating 
procedures currently remove portions of the outflow system with no knowledge of the prominent 
 174 
outflow pathways in individual eyes. If the locations of the prominent outflow pathways were 
known before surgery, it might be possible to augment and not destroy existing ostia and large 
collector channels.   
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APPENDIX A 
VOLUMETRIC AVERAGING CODE 
This code is a routine to perform 3D averaging of a volumetric image.  It is a modification of a 
sequential frame averaging routine written and owned by Dr. Hiroshi Ishikawa 
(Ishikawah@upme.edu).  It was implemented in Dr. Ishikawa’s OCT image browser software 
written in XCode for Macintosh. 
 
 
- (NSString*)VoxelAverageRaster 
{ 
 if (numFrames > 5) { 
  int size = pixelsX*pixelsY;      // size is the number 
of pixels in a frame; 1024 x a-scan count 
  int totalsize = size*numFrames;     // totalsize is the 
number of pixels in the raster scan 
  int sourceIndex, destIndex, lineIndexS, lineIndexD, enfaceIndex; 
  int *workI = malloc(size*sizeof(int));  //Single frame. 
  int i, j, k, x, y; 
  // Prepare dataBuffer 
  UInt16 *dataBuffer = malloc(totalsize*sizeof(UInt16)); 
  for (i = 1; i < numFrames*size; i++) 
   dataBuffer[i] = 0;       //initiate 
dataBuffer array (contains the entire averaged raster scan dataset) 
  // Rolling average 
  for (i = 1; i < numFrames-1; i++) {    // i counts frames 
   destIndex = i*size;       // Index 
located to start of the current frame 
   for (k = 0; k < size; k++)     // k counts locations 
within a frame 
    workI[k] = 0;       // resets the 
working frame to 0's 
   for (j = -1; j <= 1; j++) {     // j counts plus or 
minus 1 to work between three frames 
    sourceIndex = (i+j)*size;    // index to the start 
of the immediate frame (i.e. 1, 2, or 3 of the current 3 frame average). 
    lineIndexS = sourceIndex; 
    lineIndexD = destIndex; 
    for (x = 0; x < pixelsX; x++) {   // x is the x location 
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counter; covers all the a-scans along a single frame  
     for (y = 0; y < pixelsY; y++) {  // y is the y location 
counter; covers 1024 points along each a-scan 
       
      lineIndexS++; 
      workI[x*pixelsY+y] += 
(rawData[lineIndexS]+rawData[lineIndexS-pixelsY]+rawData[lineIndexS-pixelsY-
1]+rawData[lineIndexS-pixelsY+1]+rawData[lineIndexS+pixelsY]+rawData[lineIndexS+pixelsY-
1]+rawData[lineIndexS+pixelsY+1]+rawData[lineIndexS-1]+rawData[lineIndexS+1]); 
     } 
    } 
   } 
   for (x = 0; x < pixelsX; x++)  
    for (y = 0; y < pixelsY; y++)  
     dataBuffer[destIndex++] = (UInt16)(workI[x*pixelsY+y] / 27); 
  } 
  // Handle the first and last frame 
  destIndex = 0; 
  for (x = 0; x < pixelsX; x++) { 
   for (y = 0; y < pixelsY; y++) { 
    dataBuffer[destIndex] = rawData[destIndex++]; 
   } 
  } 
  destIndex = (numFrames-1)*size; 
  for (x = 0; x < pixelsX; x++) { 
   for (y = 0; y < pixelsY; y++) { 
    dataBuffer[destIndex] = rawData[destIndex++]; 
   } 
  } 
  free(workI); 
   
  // Prepare file path for exporting 
  NSString *averagePath = [[sourceFile stringByDeletingPathExtension] 
stringByAppendingString:@" VoxAvg.bog"]; 
   
  // Save averaged OCT data 
  if ([[NSFileManager defaultManager] fileExistsAtPath:averagePath]) { // If file already 
exists delete it 
   [[NSFileManager defaultManager] removeFileAtPath:averagePath handler:nil]; 
  } 
  [[NSFileManager defaultManager] createFileAtPath:averagePath contents:nil 
attributes:nil]; 
  // Setup exporting data file 
  NSFileHandle *exportFile = [NSFileHandle fileHandleForWritingAtPath:averagePath]; 
  // Write file header 
  int step = 1; 
  if (evenlySampled) 
   step = 2; 
  BioptigenDataFileHeader exportHeader; 
  exportHeader.lineCount = CFSwapInt32HostToLittle(pixelsX/step); 
  exportHeader.lineLength = CFSwapInt32HostToLittle(pixelsY*2); 
  exportHeader.frameCount = CFSwapInt32HostToLittle(numFrames); 
  exportHeader.xMin = myBogHeader.xMin; 
  exportHeader.xMax = myBogHeader.xMax; 
  exportHeader.yMin = myBogHeader.yMin; 
  exportHeader.yMax = myBogHeader.yMax; 
  exportHeader.scanDepth = myBogHeader.scanDepth; 
  exportHeader.scanLength = myBogHeader.scanLength; 
  exportHeader.azScanLength = myBogHeader.azScanLength; 
  exportHeader.elScanLength = myBogHeader.elScanLength; 
  exportHeader.objectDistance = myBogHeader.objectDistance; 
  exportHeader.scanAngle = myBogHeader.scanAngle;  
  [exportFile writeData:[NSData dataWithBytesNoCopy:&exportHeader 
length:sizeof(BioptigenDataFileHeader) freeWhenDone:NO]]; 
   
  // Write raw data (swap if necessary)  
  UInt16 *exportBuffer = malloc(pixelsX/step*pixelsY*numFrames*sizeof(UInt16)); 
  destIndex = 0; 
  int srcIndex; 
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  for (i = 0; i < numFrames; i++) { 
   srcIndex = pixelsX*pixelsY*i; 
   for (x = 0; x < pixelsX/step; x++) 
    for (y = 0; y < pixelsY; y++) 
     exportBuffer[destIndex++] = 
CFSwapInt16HostToLittle(dataBuffer[srcIndex+x*step*pixelsY+y]); 
  } 
  [exportFile writeData:[NSData dataWithBytesNoCopy:exportBuffer 
length:pixelsX/step*pixelsY*numFrames*sizeof(UInt16) freeWhenDone:NO]]; 
  free(exportBuffer); 
   
  // Finalize exporting 
  [exportFile closeFile]; 
   
  free(dataBuffer); 
   
  return averagePath;   
 } 
 else 
  return nil; 
} 
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APPENDIX B 
IMAGEJ FIJI MACROS 
A number of utility macros were written for ImageJ Fiji.  These macros allowed single keystroke 
execution of single or a sequence of existing routines.  The “process” routine at the top was used 
to prepare 3D image stacks for virtual casting.  The “size” routine resizes Cirrus OCT scans to a 
1:1 aspect ratio and scales them for direct measurement.  The various “enhance” macros allow 
experimentation with a number of enhancement strategies. 
 
macro "Process [P] "{               
 
   run("Gaussian Blur...", "sigma=1.50 stack"); 
   n=nSlices;    
    for (i=1; i<n; i++) { 
        setSlice(i); 
 run("Enhance Local Contrast (CLAHE)", "blocksize=31 histogram=256 maximum=4 
mask=*None* fast_(less_accurate)"); 
        } 
     setSlice(n); 
     run("Enhance Local Contrast (CLAHE)", "blocksize=31 histogram=256 maximum=4 
mask=*None* fast_(less_accurate)"); 
run("Gaussian Blur...", "sigma=1.5 stack"); 
run("Invert", "stack"); 
run("Subtract Background...", "rolling=30 disable stack"); 
run("Size...", "width=400 height=200 depth=400 interpolation=Bilinear"); 
} 
 
 
macro "Size [S] "{ 
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   run("Flip Vertically", "stack"); 
   n = nSlices; 
   setSlice(n); 
   run("Delete Slice"); 
   setSlice(1); 
   run("Delete Slice"); 
   run("Size...", "width=1024 height=512 depth=126 average interpolation=Bilinear"); 
   run("Set Scale...", "distance=1024 known=4000 pixel=1 unit=Micrometer"); 
 
} 
 
 
 
macro "Import Raw Image [R]"{ 
run("Raw..."); 
} 
 
 
 
macro "Enhance Fast [E] "{ 
  n = nSlices; 
    for (i=1; i<n; i++) { 
        setSlice(i); 
 run("Enhance Local Contrast (CLAHE)", "blocksize=63 histogram=256 maximum=5 
mask=*None* fast_(less_accurate)"); 
        } 
     setSlice(n); 
     run("Enhance Local Contrast (CLAHE)", "blocksize=63 histogram=256 maximum=5 
mask=*None* fast_(less_accurate)"); 
} 
 
macro "Enhance Fast 31 3 fast "{ 
  n = nSlices; 
    for (i=1; i<n; i++) { 
        setSlice(i); 
 run("Enhance Local Contrast (CLAHE)", "blocksize=31 histogram=256 maximum=3 
mask=*None* fast_(less_accurate)"); 
        } 
     setSlice(n); 
     run("Enhance Local Contrast (CLAHE)", "blocksize=31 histogram=256 maximum=3 
mask=*None* fast_(less_accurate)"); 
} 
 
macro "Last Minute Rush [L]" { 
run("Set Scale...", "distance=512 known=1 pixel=2.926 unit=mm"); 
run("Gaussian Blur...", "sigma=1.5 stack"); 
 n = nSlices; 
    for (i=1; i<n; i++) { 
        setSlice(i); 
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 run("Enhance Local Contrast (CLAHE)", "blocksize=31 histogram=256 maximum=3 
mask=*None* fast_(less_accurate)"); 
        } 
     setSlice(n); 
     run("Enhance Local Contrast (CLAHE)", "blocksize=31 histogram=256 maximum=3 
mask=*None* fast_(less_accurate)"); 
run("Gaussian Blur...", "sigma=2 stack"); 
run("8-bit"); 
run("Brightness/Contrast..."); 
} 
 
 
macro "Enhance HiRes 2 [2] "{ 
  n = nSlices; 
    for (i=1; i<n; i++) { 
        setSlice(i); 
 run("Enhance Local Contrast (CLAHE)", "blocksize=63 histogram=256 maximum=2 
mask=*None*"); 
        } 
     setSlice(n); 
     run("Enhance Local Contrast (CLAHE)", "blocksize=63 histogram=256 maximum=2 
mask=*None*"); 
} 
 
 
 
macro "Enhance Fast 31 4 fast "{ 
  n = nSlices; 
    for (i=1; i<n; i++) { 
        setSlice(i); 
 run("Enhance Local Contrast (CLAHE)", "blocksize=31 histogram=256 maximum=4 
mask=*None* fast_(less_accurate)"); 
        } 
     setSlice(n); 
     run("Enhance Local Contrast (CLAHE)", "blocksize=31 histogram=256 maximum=4 
mask=*None* fast_(less_accurate)"); 
} 
 
 
 
macro "Enhance Fast 31 5 fast "{ 
  n = nSlices; 
    for (i=1; i<n; i++) { 
        setSlice(i); 
 run("Enhance Local Contrast (CLAHE)", "blocksize=31 histogram=256 maximum=5 
mask=*None* fast_(less_accurate)"); 
        } 
     setSlice(n); 
     run("Enhance Local Contrast (CLAHE)", "blocksize=31 histogram=256 maximum=5 
mask=*None* fast_(less_accurate)"); 
} 
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macro "Enhance Fast 31 6 fast "{ 
  n = nSlices; 
    for (i=1; i<n; i++) { 
        setSlice(i); 
 run("Enhance Local Contrast (CLAHE)", "blocksize=31 histogram=256 maximum=6 
mask=*None* fast_(less_accurate)"); 
        } 
     setSlice(n); 
     run("Enhance Local Contrast (CLAHE)", "blocksize=31 histogram=256 maximum=6 
mask=*None* fast_(less_accurate)"); 
} 
 
 
 
 
 
 
 
 
macro "Enhance HiRes 2 [2] "{ 
  n = nSlices; 
    for (i=1; i<n; i++) { 
        setSlice(i); 
 run("Enhance Local Contrast (CLAHE)", "blocksize=63 histogram=256 maximum=2 
mask=*None*"); 
        } 
     setSlice(n); 
     run("Enhance Local Contrast (CLAHE)", "blocksize=63 histogram=256 maximum=2 
mask=*None*"); 
} 
 
 
 
macro "Enhance HiRes 3 [3] "{ 
  n = nSlices; 
    for (i=1; i<n; i++) { 
        setSlice(i); 
 run("Enhance Local Contrast (CLAHE)", "blocksize=63 histogram=256 maximum=3 
mask=*None*"); 
        } 
     setSlice(n); 
     run("Enhance Local Contrast (CLAHE)", "blocksize=63 histogram=256 maximum=3 
mask=*None*"); 
} 
 
macro "Enhance HiRes 4 [4] "{ 
  n = nSlices; 
    for (i=1; i<n; i++) { 
        setSlice(i); 
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 run("Enhance Local Contrast (CLAHE)", "blocksize=63 histogram=256 maximum=4 
mask=*None*"); 
        } 
     setSlice(n); 
     run("Enhance Local Contrast (CLAHE)", "blocksize=63 histogram=256 maximum=4 
mask=*None*"); 
} 
 
 
macro "Enhance HiRes 5 [5] "{ 
  n = nSlices; 
    for (i=1; i<n; i++) { 
        setSlice(i); 
 run("Enhance Local Contrast (CLAHE)", "blocksize=63 histogram=256 maximum=5 
mask=*None*"); 
        } 
     setSlice(n); 
     run("Enhance Local Contrast (CLAHE)", "blocksize=63 histogram=256 maximum=5 
mask=*None*"); 
} 
 
 
macro "Enhance HiRes 6 [6] "{ 
  n = nSlices; 
    for (i=1; i<n; i++) { 
        setSlice(i); 
 run("Enhance Local Contrast (CLAHE)", "blocksize=63 histogram=256 maximum=6 
mask=*None*"); 
        } 
     setSlice(n); 
     run("Enhance Local Contrast (CLAHE)", "blocksize=63 histogram=256 maximum=6 
mask=*None*"); 
} 
 
 
macro "Delete Slice [D]" { 
     run("Delete Slice"); 
 } 
 
macro "Setup TIF File"{ 
run("Size...", "width=1024 height=1024 depth=20 average interpolation=Bilinear"); 
run("Set Scale...", "distance=1024 known=2 pixel=1 unit=Micrometer"); 
makeRectangle(644, 842, 254, 28); 
run("Fill", "stack"); 
run("Set Scale...", "distance=512 known=1000 pixel=1 unit=Micrometer"); 
} 
 
macro "Doppler Processing " { 
run("Rotate 90 Degrees Right"); 
run("Minimum...", "radius=3 stack"); 
run("Gaussian Blur...", "sigma=6 stack"); 
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run("Subtract Background...", "rolling=20 light disable stack"); 
run("8-bit"); 
run("Brightness/Contrast..."); 
} 
 
macro "Doppler Processing " { 
run("Size...", "width=1024 height=1024 interpolation=Bilinear"); 
run("Make Binary", "calculate"); 
run("Analyze Particles...", "size=250-Infinity circularity=0.00-1.00 show=Nothing exclude clear 
add stack"); 
setOption("Show All",false); 
} 
 
macro "Jump to Slice [J]" { 
Slic=getNumber('Jump to slice #?',1); 
setSlice(Slic); 
} 
 
 
macro "SET TO 8 BIT [8]" { 
run("8-bit"); 
} 
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APPENDIX C 
5X5 PLANAR AVERAGING 
This code is a routine to perform averaging of a volumetric image using a flat 5x5 averaging 
kernel.  It is a modification of a sequential frame averaging routine written and owned by Dr. 
Hiroshi Ishikawa (Ishikawah@upme.edu).  It was implemented in Dr. Ishikawa’s OCT image 
browser software written in XCode for Macintosh. 
 
 
- (NSString*)TwentyfiveAverageRaster 
{ 
 if (numFrames > 5) { 
  int size = pixelsX*pixelsY; 
  int sourceIndex, destIndex, lineIndexS, lineIndexD, enfaceIndex; 
  UInt32 *workI = malloc(pixelsX*pixelsY*sizeof(UInt32)); 
  int i, j, k, x, y; 
  // Prepare dataBuffer 
  UInt16 *dataBuffer = malloc(size*numFrames*sizeof(UInt16)); 
  for (i = 1; i < numFrames*size; i++) 
   dataBuffer[i] = 0; 
  // Rolling average 
  for (i = 2; i < numFrames-2; i++) {    //changed the 2's from1 1's.   
   destIndex = i*size; 
   for (k = 0; k < pixelsX*pixelsY; k++) 
    workI[k] = 0; 
   for (j = -2; j <= 2; j++) {     //changed the 2's 
from1 1's.  
    sourceIndex = (i+j)*size; 
    lineIndexS = sourceIndex; 
    lineIndexD = destIndex; 
    for (x = 0; x < pixelsX; x++) { 
     for (y = 0; y < pixelsY; y++) { 
       
 
       
      if(x == 0){ 
       lineIndexS++;       
       workI[x*pixelsY+y] += 
(rawData[lineIndexS]+rawData[lineIndexS]+rawData[lineIndexS]+rawData[lineIndexS+pixelsY]+rawData[
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lineIndexS+pixelsY+pixelsY]); 
       } 
       if(x == 1){ 
       lineIndexS++;       
       workI[x*pixelsY+y] += (rawData[lineIndexS-
pixelsY]+rawData[lineIndexS]+rawData[lineIndexS]+rawData[lineIndexS+pixelsY]+rawData[lineIndexS+p
ixelsY+pixelsY]); 
       } 
        
       if (x > 1 && x < pixelsX-2) { 
       lineIndexS++;       
       workI[x*pixelsY+y] += 
(rawData[lineIndexS]+rawData[lineIndexS-pixelsY]+rawData[lineIndexS+pixelsY]+rawData[lineIndexS-
pixelsY-pixelsY]+rawData[lineIndexS+pixelsY+pixelsY]); 
       } 
        
       if(x == pixelsX-2) { 
       lineIndexS++;       
       workI[x*pixelsY+y] += 
(rawData[lineIndexS]+rawData[lineIndexS-pixelsY]+rawData[lineIndexS-pixelsY-
pixelsY]+rawData[lineIndexS]+rawData[lineIndexS+pixelsY]); 
       }  
       if(x == pixelsX-1) { 
       lineIndexS++;       
       workI[x*pixelsY+y] += 
(rawData[lineIndexS]+rawData[lineIndexS-pixelsY]+rawData[lineIndexS-pixelsY-
pixelsY]+rawData[lineIndexS]+rawData[lineIndexS]); 
       
       
       
       
/*      if(x == 0){ 
       lineIndexS++;       
       workI[x*pixelsY+y] += 
(rawData[lineIndexS]+rawData[lineIndexS]+rawData[lineIndexS]+rawData[lineIndexS+pixelsY]+rawData[
lineIndexS+pixelsY+pixelsY]); 
      } 
      if(x == 1){ 
       lineIndexS++;       
       workI[x*pixelsY+y] += (rawData[lineIndexS-
pixelsY]+rawData[lineIndexS]+rawData[lineIndexS]+rawData[lineIndexS+pixelsY]+rawData[lineIndexS+p
ixelsY+pixelsY]); 
      } 
       
      if (x > 1 && x < pixelsX-2) { 
       lineIndexS++;       
       workI[x*pixelsY+y] += 
(rawData[lineIndexS]+rawData[lineIndexS-pixelsY]+rawData[lineIndexS+pixelsY]+rawData[lineIndexS-
pixelsY-pixelsY]+rawData[lineIndexS+pixelsY+pixelsY]); 
      } 
       
      if(x == pixelsX-2) { 
       lineIndexS++;       
       workI[x*pixelsY+y] += 
(rawData[lineIndexS]+rawData[lineIndexS-pixelsY]+rawData[lineIndexS-pixelsY-
pixelsY]+rawData[lineIndexS]+rawData[lineIndexS+pixelsY]); 
      }  
      if(x == pixelsX-1) { 
       lineIndexS++;       
       workI[x*pixelsY+y] += 
(rawData[lineIndexS]+rawData[lineIndexS-pixelsY]+rawData[lineIndexS-pixelsY-
pixelsY]+rawData[lineIndexS]+rawData[lineIndexS]); */ 
      }  
     } 
    } 
   } 
   for (x = 0; x < pixelsX; x++)  
    for (y = 0; y < pixelsY; y++)  
     dataBuffer[destIndex++] = workI[x*pixelsY+y] / 4;   //THIS NEEDS TO 
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BE / 25 WHEN PUT BACK TO 5X5!!!!!!  
  } 
  // Handle the first and last frame 
  destIndex = 0; 
  for (x = 0; x < pixelsX; x++) {     //Write one frame 
   for (y = 0; y < pixelsY; y++) { 
    dataBuffer[destIndex] = rawData[destIndex++]; 
   } 
  } 
  for (x = 0; x < pixelsX; x++) {     // Write another frame 
   for (y = 0; y < pixelsY; y++) { 
    dataBuffer[destIndex] = rawData[destIndex++]; 
   } 
  } 
 
   
  destIndex = (numFrames-2)*size; 
  for (x = 0; x < pixelsX; x++) {     // Write second to 
last frame frame 
   for (y = 0; y < pixelsY; y++) { 
    dataBuffer[destIndex] = rawData[destIndex++]; 
   } 
  } 
  for (x = 0; x < pixelsX; x++) {     // Write the last one 
   for (y = 0; y < pixelsY; y++) { 
    dataBuffer[destIndex] = rawData[destIndex++]; 
   } 
  } 
 
  free(workI); 
   
  // Prepare file path for exporting 
  NSString *averagePath = [[sourceFile stringByDeletingPathExtension] 
stringByAppendingString:@"_Flat25.bog"]; 
   
  // Save averaged OCT data 
  if ([[NSFileManager defaultManager] fileExistsAtPath:averagePath]) { // If file already 
exists delete it 
   [[NSFileManager defaultManager] removeFileAtPath:averagePath handler:nil]; 
  } 
  [[NSFileManager defaultManager] createFileAtPath:averagePath contents:nil 
attributes:nil]; 
  // Setup exporting data file 
  NSFileHandle *exportFile = [NSFileHandle fileHandleForWritingAtPath:averagePath]; 
  // Write file header 
  int step = 1; 
  if (evenlySampled) 
   step = 2; 
  BioptigenDataFileHeader exportHeader; 
  exportHeader.lineCount = CFSwapInt32HostToLittle(pixelsX/step); 
  exportHeader.lineLength = CFSwapInt32HostToLittle(pixelsY*2); 
  exportHeader.frameCount = CFSwapInt32HostToLittle(numFrames); 
  exportHeader.xMin = myBogHeader.xMin; 
  exportHeader.xMax = myBogHeader.xMax; 
  exportHeader.yMin = myBogHeader.yMin; 
  exportHeader.yMax = myBogHeader.yMax; 
  exportHeader.scanDepth = myBogHeader.scanDepth; 
  exportHeader.scanLength = myBogHeader.scanLength; 
  exportHeader.azScanLength = myBogHeader.azScanLength; 
  exportHeader.elScanLength = myBogHeader.elScanLength; 
  exportHeader.objectDistance = myBogHeader.objectDistance; 
  exportHeader.scanAngle = myBogHeader.scanAngle;  
  [exportFile writeData:[NSData dataWithBytesNoCopy:&exportHeader 
length:sizeof(BioptigenDataFileHeader) freeWhenDone:NO]]; 
   
  // Write raw data (swap if necessary)  
  UInt16 *exportBuffer = malloc(pixelsX/step*pixelsY*numFrames*sizeof(UInt16)); 
  destIndex = 0; 
  int srcIndex; 
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  for (i = 0; i < numFrames; i++) { 
   srcIndex = pixelsX*pixelsY*i; 
   for (x = 0; x < pixelsX/step; x++) 
    for (y = 0; y < pixelsY; y++) 
     exportBuffer[destIndex++] = 
CFSwapInt16HostToLittle(dataBuffer[srcIndex+x*step*pixelsY+y]); 
  } 
  [exportFile writeData:[NSData dataWithBytesNoCopy:exportBuffer 
length:pixelsX/step*pixelsY*numFrames*sizeof(UInt16) freeWhenDone:NO]]; 
  free(exportBuffer); 
   
  // Finalize exporting 
  [exportFile closeFile]; 
   
  free(dataBuffer); 
   
  return averagePath;   
 } 
 else 
  return nil; 
} 
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